This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other abnormalities of plasma proteins
R18_OTHER_ABNORMALITI_PLASMA_PROTEINS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
610 |
4. Check minimum number of eventsNone |
610 |
5. Include endpointsNone |
610 |
6. Filter based on genotype QC (FinnGen only) |
593 |
Control definitions (FinnGen only)
- Control exclude
- R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R7
- Name in latin
- Aliae abnormitates proteinorum plasmatis
Similar endpoints
↥List of similar endpoints to
Other abnormalities of plasma proteins
based on the number of shared cases.
Similar with more cases:
- Abnormal findings on examination of blood, without diagnosis
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 593 | 293 | 300 |
| Unadjusted period prevalence (%) | 0.12 | 0.10 | 0.14 |
| Median age at first event (years) | 67.08 | 65.07 | 69.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 610
- Matched controls
- 6100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R77.1
ICD-10 Finland
Abnormality of globulin
2814.5
204.1
186
*
R77.0
ICD-10 Finland
Abnormality of albumin
+∞
196.8
178
*
R77.8
ICD-10 Finland
Other specified abnormalities of plasma proteins
836.0
192.1
179
*
R77.9
ICD-10 Finland
Abnormality of plasma protein, unspecified
+∞
73.4
69
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
25.6
60.7
43
18
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.5
54.2
162
450
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
43.5
160
511
R50.9
ICD-10 Finland
Fever, unspecified
3.5
37.0
164
586
C03CA01
ATC
furosemide; systemic
2.9
36.1
302
1547
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
36.0
403
2406
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
31.9
249
1213
JN4AD
NOMESCO Finland
Body CT examination
3.4
31.5
133
457
D64.9
ICD-10 Finland
Anaemia, unspecified
3.5
30.6
125
420
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
28.8
170
708
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
11.6
28.6
30
27
XW000
NOMESCO Finland
Bone marrow biopsy
5.0
27.7
63
137
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
27.7
187
835
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
26.3
242
1254
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
23.4
125
488
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
31.5
23.0
30
10
ZX120
NOMESCO Finland
Intravenous
3.2
21.0
94
331
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
20.1
88
305
H02AB06
ATC
prednisolone; systemic
2.2
19.3
338
2222
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
18.7
106
424
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
18.5
72
232
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.2
18.4
32
54
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.9
18.0
28
42
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
17.9
108
446
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
17.9
66
205
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
17.8
142
672
A41.9
ICD-10 Finland
Sepsis, unspecified
4.3
16.9
45
111
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
16.7
120
540
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.6
16.0
31
58
A02BC02
ATC
pantoprazole; systemic
2.2
15.9
454
3480
AA1AD
NOMESCO Finland
CT of head and brain
2.1
15.4
227
1367
N02AA05
ATC
oxycodone; systemic
2.2
15.3
165
883
Z51.5
ICD-10 Finland
Palliative care
2.7
15.0
92
382
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.9
14.7
45
123
J94.8
ICD-10 Finland
Other specified pleural conditions
6.5
14.7
24
38
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
14.3
167
917
JN4BD
NOMESCO Finland
Extensive body CT
2.6
14.0
92
395
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.9
13.9
42
114
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.5
13.9
50
153
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
13.7
119
579
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.8
13.6
43
120
A46
ICD-10 Finland
Erysipelas
2.3
13.6
119
581
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.6
13.6
47
140
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.6
13.3
45
132
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.8
13.0
24
43
R60.9
ICD-10 Finland
Oedema, unspecified
3.1
12.8
55
188
WW200
NOMESCO Finland
Immunization
5.1
12.7
27
55
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.7
12.6
70
275
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
12.6
241
1563
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
12.5
72
289
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
12.4
75
308
ZXD05
NOMESCO Finland
Urgent procedure
1.9
12.1
203
1258
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.1
12.1
33
83
SPAT1262
SPAT
Handing over of treatment supplies
2.1
11.8
128
680
R11
ICD-10 Finland
Nausea and vomiting
2.5
11.8
77
329
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.5
11.7
41
123
A11CC03
ATC
alfacalcidol; systemic
4.7
11.5
27
60
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.0
11.5
33
86
J01MA12
ATC
levofloxacin; systemic
2.0
11.5
139
768
R06.0
ICD-10 Finland
Dyspnoea
1.9
11.4
201
1263
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
11.3
106
531
ZXE00
NOMESCO Finland
One hour or less
1.8
11.2
250
1688
A04AA01
ATC
ondansetron; systemic, rectal
2.6
11.0
69
288
R18
ICD-10 Finland
Ascites
4.8
11.0
25
54
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
11.0
182
1118
WZC30
NOMESCO Finland
Teaching
2.1
10.9
123
660
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.0
10.9
50
177
J01MA02
ATC
ciprofloxacin; systemic
1.8
10.9
260
1787
SPAT1229
SPAT
Assessment of need for aid
2.6
10.8
65
266
TK800
NOMESCO Finland
Hemodialysis
4.9
10.8
24
51
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
61.1
10.7
12
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
10.6
257
1769
B01AB10
ATC
tinzaparin; parenteral
2.3
10.6
87
411
A41.8
ICD-10 Finland
Other specified sepsis
4.6
10.6
25
56
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.6
10.5
20
37
N18.8
ICD-10 Finland
Other chronic renal failure
4.3
10.5
27
65
R60.0
ICD-10 Finland
Localized oedema
2.2
10.4
100
504
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
10.4
175
1078
E87.5
ICD-10 Finland
Hyperkalaemia
4.7
10.3
24
53
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.7
10.3
24
53
B01AB05
ATC
enoxaparin; parenteral
1.8
10.2
216
1425
UJF32
NOMESCO Finland
Coloscopy
1.8
10.2
184
1157
L04AA06
ATC
mycophenolic acid; systemic
5.4
10.2
20
38
B03XA02
ATC
darbepoetin alfa; parenteral
4.4
9.9
25
59
E83.1
ICD-10 Finland
Disorders of iron metabolism
20.4
9.8
14
7
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.8
9.8
22
47
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.4
9.7
36
112
L28
ICPC
Limited function/disability (L)
1.9
9.7
142
833
I50.0
ICD-10 Finland
Congestive heart failure
2.4
9.6
69
307
C03DA01
ATC
spironolactone; oral
2.1
9.6
101
527
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.5
9.4
23
53
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
9.2
234
1620
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
9.1
224
1535
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
9.1
55
226
B01AA03
ATC
warfarin; systemic
1.9
9.0
141
844
R53
ICD-10 Finland
Malaise and fatigue
1.8
9.0
176
1128
Z3231
NOMESCO Finland
Registered nurse
1.8
8.9
177
1141
WW500
NOMESCO Finland
Blood transfusion
3.1
8.8
37
125
J01DB01
ATC
cefalexin; oral
1.9
8.7
499
4279
H02AB09
ATC
hydrocortisone; systemic
4.4
8.7
22
52
UJF92
NOMESCO Finland
Capsular endoscopy
4.4
8.7
22
52
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.7
8.7
47
182
M35.3
ICD-10 Finland
Polymyalgia rheumatica
3.0
8.5
39
138
E86
ICD-10 Finland
Volume depletion
3.7
8.5
27
76
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
8.5
49
197
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
8.4
35
117
R4190
NOMESCO Finland
Nutritional therapy
3.2
8.4
33
107
R77
ICD-10 Finland
Other abnormalities of plasma proteins
+∞
8.3
8
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
8.2
90
476
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
8.2
60
270
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
8.1
71
344
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
8.1
87
457
R4110
NOMESCO Finland
Physiotherapy
1.7
8.0
176
1161
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
8.0
50
209
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
7.9
222
1562
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.7
7.9
41
156
WX002
NOMESCO Finland
Sedation and analgesia
1.8
7.8
128
774
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
7.8
74
370
SPAT1255
SPAT
Intravenous administration of medicine
2.5
7.8
50
211
H02AB02
ATC
dexamethasone; systemic
2.0
7.8
84
441
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
7.8
150
953
SPAT1301
SPAT
No procedures
1.7
7.8
198
1358
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.6
7.7
17
23
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
7.7
74
373
M04AA01
ATC
allopurinol; systemic
1.9
7.6
99
556
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.8
7.6
37
136
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.8
7.5
23
63
SPAT1263
SPAT
Sampling
1.6
7.5
251
1840
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
7.5
42
166
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
7.5
94
521
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
7.5
113
666
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.8
7.4
16
21
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
2.8
7.4
36
132
L04AX01
ATC
azathioprine; systemic
3.1
7.4
30
99
196
Kela drug reimbursment
Paricalcitol and cinacalcet
13.6
7.4
12
9
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
7.4
63
302
JN4CD
NOMESCO Finland
Very extensive body CT
2.9
7.3
35
127
116
Kela drug reimbursment
Prostate cancer
2.7
7.3
40
156
WX882
NOMESCO Finland
High dependency care
3.4
7.3
26
79
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
9.5
7.3
14
15
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.7
7.3
39
151
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
7.2
105
612
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.4
7.2
25
75
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.2
140
891
SPAT1254
SPAT
Administration of medicine
1.9
7.1
100
575
M10.9
ICD-10 Finland
Gout, unspecified
2.3
7.1
56
260
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.4
7.1
50
221
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.9
7.0
20
52
N03AX16
ATC
[U] pregabalin
1.7
7.0
147
954
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.4
6.9
50
223
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.2
6.9
60
290
K77
ICPC
Heart failure
3.3
6.9
25
77
C90.0
ICD-10 Finland
Multiple myeloma
6.2
6.8
17
28
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.8
6.8
18
32
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.6
6.8
22
63
A10AB05
ATC
insulin aspart; parenteral
2.2
6.7
55
260
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.0
6.6
28
95
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.5
6.6
22
64
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.1
6.6
27
90
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.1
6.6
61
303
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
6.5
92
530
N02AX02
ATC
tramadol; systemic, rectal
1.6
6.5
268
2045
V03AE01
ATC
polystyrene sulfonate; oral
5.8
6.5
17
30
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.8
6.5
17
30
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.6
6.5
21
60
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.8
6.4
32
119
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
2.7
6.4
33
125
L03AA13
ATC
pegfilgrastim; parenteral
2.6
6.4
35
137
KH1AD
NOMESCO Finland
CT of urinary organs
3.0
6.4
28
97
J01MA14
ATC
moxifloxacin; systemic
2.1
6.4
64
327
XKD00
NOMESCO Finland
Uroflowmetry
1.8
6.4
103
619
TQW80
NOMESCO Finland
Local dermatologic skincare
3.4
6.3
22
66
N02BE01
ATC
paracetamol; systemic, rectal
1.9
6.3
541
4896
A04
ICPC
Weakness/tiredness general
1.8
6.2
104
630
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
27.0
6.2
8
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
6.2
152
1023
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.9
6.2
28
99
A28
ICPC
Limited function/disability NOS
1.7
6.1
129
835
E0000UV, ,
ATC
1.5
6.1
243
1834
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
6.8
6.1
14
21
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
10.2
6.1
11
11
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.1
6.0
15
25
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
6.0
74
407
SPAT1310
SPAT
Counselling related to known health issue
1.6
6.0
185
1316
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
33944-0 [3047169]
1.2e+00
2.1e+00
3.7e+00
1.0e+50
3.7e+00
3.1e+00
1.8e+00
cases:2.30%
controls:0.69%
cases:3.62%
controls:0.44%
cases:3.29%
controls:0.08%
cases:1.15%
controls:0.00%
cases:4.03%
controls:0.10%
cases:7.36%
controls:0.36%
cases:7.89%
controls:1.38%
14
42
594
6048
22
27
586
6063
20
5
588
6085
7
0
601
6090
24
6
572
6059
38
21
478
5804
30
63
350
4517
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
36916-5 [3034860]
1.2e+00
2.1e+00
3.7e+00
1.0e+50
3.7e+00
3.1e+00
1.8e+00
cases:2.30%
controls:0.69%
cases:3.62%
controls:0.44%
cases:3.29%
controls:0.08%
cases:1.15%
controls:0.00%
cases:4.03%
controls:0.10%
cases:7.17%
controls:0.36%
cases:7.89%
controls:1.38%
14
42
594
6048
22
27
586
6063
20
5
588
6085
7
0
601
6090
24
6
572
6059
37
21
479
5804
30
63
350
4517
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
5.5e-01
1.5e+00
2.9e+00
4.4e+00
3.4e+00
1.7e+00
1.0e+00
cases:19.24%
controls:12.10%
cases:25.99%
controls:7.04%
cases:15.79%
controls:1.05%
cases:7.40%
controls:0.10%
cases:22.82%
controls:0.96%
cases:27.91%
controls:6.47%
cases:35.26%
controls:16.18%
117
737
491
5353
158
429
450
5661
96
64
512
6026
45
6
563
6084
136
58
460
6007
144
377
372
5448
134
741
246
3839
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
1.1e+00
2.4e+00
3.6e+00
1.0e+50
4.0e+00
2.7e+00
1.7e+00
cases:5.10%
controls:1.82%
cases:8.55%
controls:0.80%
cases:5.10%
controls:0.15%
cases:1.81%
controls:0.00%
cases:7.55%
controls:0.15%
cases:10.27%
controls:0.76%
cases:12.89%
controls:2.60%
31
111
577
5979
52
49
556
6041
31
9
577
6081
11
0
597
6090
45
9
551
6056
53
44
463
5781
49
119
331
4461
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
9.9e-01
2.2e+00
3.8e+00
1.0e+50
4.1e+00
2.4e+00
1.8e+00
cases:4.77%
controls:1.82%
cases:6.58%
controls:0.76%
cases:4.28%
controls:0.10%
cases:0.99%
controls:0.00%
cases:5.54%
controls:0.10%
cases:8.91%
controls:0.89%
cases:11.84%
controls:2.14%
29
111
579
5979
40
46
568
6044
26
6
582
6084
6
0
602
6090
33
6
563
6059
46
52
470
5773
45
98
335
4482
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
8.1e-01
2.3e+00
3.8e+00
1.0e+50
4.0e+00
2.7e+00
1.6e+00
cases:3.78%
controls:1.72%
cases:6.58%
controls:0.69%
cases:4.11%
controls:0.10%
cases:1.48%
controls:0.00%
cases:6.21%
controls:0.12%
cases:8.53%
controls:0.60%
cases:10.26%
controls:2.23%
23
105
585
5985
40
42
568
6048
25
6
583
6084
9
0
599
6090
37
7
559
6058
44
35
472
5790
39
102
341
4478
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
1.2e+00
2.4e+00
3.8e+00
—
3.6e+00
2.7e+00
1.3e+00
cases:4.11%
controls:1.28%
cases:5.76%
controls:0.54%
cases:3.62%
controls:0.08%
—
—
cases:3.02%
controls:0.08%
cases:5.81%
controls:0.39%
cases:7.11%
controls:1.97%
25
78
583
6012
35
33
573
6057
22
5
586
6085
—
18
5
578
6060
30
23
486
5802
27
90
353
4490
Inpatient Hospital
21 [8717]
21 [8717]
3.4e-01
1.1e+00
2.4e+00
5.9e+00
2.6e+00
1.2e+00
7.5e-01
cases:40.79%
controls:32.81%
cases:25.16%
controls:9.89%
cases:11.68%
controls:1.20%
cases:23.36%
controls:0.08%
cases:16.95%
controls:1.52%
cases:24.61%
controls:8.79%
cases:36.84%
controls:21.64%
248
1998
360
4092
153
602
455
5488
71
73
537
6017
142
5
466
6085
101
92
495
5973
127
512
389
5313
140
991
240
3589
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
1.2e+00
2.0e+00
3.3e+00
1.0e+50
4.4e+00
2.1e+00
1.2e+00
cases:5.43%
controls:1.71%
cases:6.41%
controls:0.94%
cases:2.96%
controls:0.11%
cases:0.99%
controls:0.00%
cases:7.72%
controls:0.10%
cases:7.36%
controls:0.93%
cases:7.63%
controls:2.38%
33
104
575
5986
39
57
569
6033
18
7
590
6083
6
0
602
6090
46
6
550
6059
38
54
478
5771
29
109
351
4471
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.8e-01
1.3e+00
2.6e+00
5.2e+00
2.6e+00
1.2e+00
7.5e-01
cases:36.18%
controls:25.98%
cases:40.79%
controls:16.35%
cases:29.93%
controls:3.10%
cases:12.83%
controls:0.08%
cases:28.52%
controls:2.85%
cases:39.73%
controls:16.15%
cases:51.84%
controls:33.60%
220
1582
388
4508
248
996
360
5094
182
189
426
5901
78
5
530
6085
170
173
426
5892
205
941
311
4884
197
1539
183
3041
Infectious Disease
44 [38004484]
44 [38004484]
1.2e+00
2.0e+00
3.3e+00
1.0e+50
3.1e+00
2.8e+00
1.5e+00
cases:5.92%
controls:1.92%
cases:5.92%
controls:0.85%
cases:3.13%
controls:0.11%
cases:6.25%
controls:0.00%
cases:4.70%
controls:0.21%
cases:8.33%
controls:0.57%
cases:10.26%
controls:2.51%
36
117
572
5973
36
52
572
6038
19
7
589
6083
38
0
570
6090
28
13
568
6052
43
33
473
5792
39
115
341
4465
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
6.0e-01
1.2e+00
2.5e+00
4.9e+00
2.7e+00
1.2e+00
8.1e-01
cases:19.90%
controls:12.00%
cases:26.32%
controls:9.56%
cases:18.42%
controls:1.90%
cases:11.68%
controls:0.10%
cases:19.13%
controls:1.60%
cases:26.74%
controls:9.87%
cases:35.53%
controls:19.74%
121
731
487
5359
160
582
448
5508
112
116
496
5974
71
6
537
6084
114
97
482
5968
138
575
378
5250
135
904
245
3676
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
4.0e-01
1.3e+00
2.3e+00
4.6e+00
2.7e+00
1.4e+00
8.3e-01
cases:23.19%
controls:16.77%
cases:31.25%
controls:10.64%
cases:20.72%
controls:2.59%
cases:10.03%
controls:0.11%
cases:25.34%
controls:2.32%
cases:32.36%
controls:10.66%
cases:39.74%
controls:22.27%
141
1021
467
5069
190
648
418
5442
126
158
482
5932
61
7
547
6083
151
141
445
5924
167
621
349
5204
151
1020
229
3560
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
1.2e+00
2.2e+00
2.5e+00
—
2.8e+00
2.4e+00
1.8e+00
cases:4.28%
controls:1.36%
cases:3.29%
controls:0.38%
cases:1.64%
controls:0.13%
—
—
cases:1.85%
controls:0.12%
cases:4.65%
controls:0.43%
cases:6.58%
controls:1.11%
26
83
582
6007
20
23
588
6067
10
8
598
6082
—
11
7
585
6058
24
25
492
5800
25
51
355
4529
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
1.1e+00
2.0e+00
2.9e+00
1.0e+50
3.8e+00
2.1e+00
1.0e+00
cases:9.70%
controls:3.58%
cases:11.35%
controls:1.69%
cases:4.93%
controls:0.30%
cases:1.97%
controls:0.00%
cases:10.91%
controls:0.28%
cases:10.66%
controls:1.42%
cases:12.11%
controls:4.72%
59
218
549
5872
69
103
539
5987
30
18
578
6072
12
0
596
6090
65
17
531
6048
55
83
461
5742
46
216
334
4364
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.0e-01
9.6e-01
2.5e+00
5.2e+00
2.6e+00
1.0e+00
3.5e-01
cases:46.55%
controls:39.29%
cases:46.88%
controls:25.27%
cases:39.14%
controls:4.84%
cases:36.18%
controls:0.31%
cases:41.11%
controls:4.91%
cases:47.87%
controls:25.13%
cases:59.21%
controls:50.46%
283
2393
325
3697
285
1539
323
4551
238
295
370
5795
220
19
388
6071
245
298
351
5767
247
1464
269
4361
225
2311
155
2269
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
7.5e-01
1.9e+00
3.8e+00
—
3.6e+00
1.6e+00
8.5e-01
cases:12.01%
controls:6.04%
cases:16.45%
controls:2.89%
cases:11.84%
controls:0.30%
—
—
cases:11.41%
controls:0.35%
cases:12.98%
controls:2.90%
cases:20.26%
controls:9.78%
73
368
535
5722
100
176
508
5914
72
18
536
6072
—
68
21
528
6044
67
169
449
5656
77
448
303
4132
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
WD125 [2001310680]
2.0e+00
2.5e+00
2.6e+00
—
2.9e+00
2.4e+00
—
cases:1.64%
controls:0.23%
cases:2.80%
controls:0.23%
cases:1.81%
controls:0.13%
—
—
cases:1.51%
controls:0.08%
cases:2.13%
controls:0.21%
—
—
10
14
598
6076
17
14
591
6076
11
8
597
6082
—
9
5
587
6060
11
12
505
5813
—
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
4.6e-01
1.9e+00
3.6e+00
—
4.1e+00
1.8e+00
9.7e-01
cases:4.44%
controls:2.86%
cases:5.43%
controls:0.87%
cases:3.62%
controls:0.10%
—
—
cases:5.70%
controls:0.10%
cases:5.04%
controls:0.88%
cases:8.42%
controls:3.38%
27
174
581
5916
33
53
575
6037
22
6
586
6084
—
34
6
562
6059
26
51
490
5774
32
155
348
4425
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
1.0e+00
2.0e+00
3.0e+00
1.0e+50
3.3e+00
2.1e+00
9.3e-01
cases:7.57%
controls:2.84%
cases:12.01%
controls:1.84%
cases:4.93%
controls:0.25%
cases:1.15%
controls:0.00%
cases:7.72%
controls:0.30%
cases:13.57%
controls:1.97%
cases:15.26%
controls:6.64%
46
173
562
5917
73
112
535
5978
30
15
578
6075
7
0
601
6090
46
18
550
6047
70
115
446
5710
58
304
322
4276
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
1.0e+00
1.8e+00
3.2e+00
1.0e+50
3.3e+00
1.9e+00
1.1e+00
cases:5.76%
controls:2.18%
cases:8.72%
controls:1.56%
cases:5.26%
controls:0.23%
cases:1.32%
controls:0.00%
cases:6.38%
controls:0.25%
cases:9.88%
controls:1.55%
cases:13.16%
controls:4.76%
35
133
573
5957
53
95
555
5995
32
14
576
6076
8
0
600
6090
38
15
558
6050
51
90
465
5735
50
218
330
4362
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
1.2e+00
1.9e+00
3.0e+00
1.0e+50
3.2e+00
1.9e+00
1.1e+00
cases:7.89%
controls:2.58%
cases:8.22%
controls:1.26%
cases:2.80%
controls:0.15%
cases:3.95%
controls:0.00%
cases:5.03%
controls:0.21%
cases:7.56%
controls:1.24%
cases:9.74%
controls:3.32%
48
157
560
5933
50
77
558
6013
17
9
591
6081
24
0
584
6090
30
13
566
6052
39
72
477
5753
37
152
343
4428
Metastasis
OMOP4998856 [36769180]
OMOP4998856 [36769180]
2.3e+00
2.5e+00
2.9e+00
1.0e+50
2.7e+00
1.8e+00
1.6e+00
cases:1.64%
controls:0.16%
cases:2.47%
controls:0.20%
cases:2.30%
controls:0.13%
cases:1.97%
controls:0.00%
cases:2.52%
controls:0.16%
cases:1.55%
controls:0.26%
cases:1.84%
controls:0.37%
10
10
598
6080
15
12
593
6078
14
8
594
6082
12
0
596
6090
15
10
581
6055
8
15
508
5810
7
17
373
4563
Secondary malignant neoplasm of other specified sites
C79.8 [45547524]
C79.8 [45547524]
2.3e+00
2.5e+00
2.9e+00
1.0e+50
2.7e+00
1.8e+00
1.6e+00
cases:1.64%
controls:0.16%
cases:2.47%
controls:0.20%
cases:2.30%
controls:0.13%
cases:1.97%
controls:0.00%
cases:2.52%
controls:0.16%
cases:1.55%
controls:0.26%
cases:1.58%
controls:0.33%
10
10
598
6080
15
12
593
6078
14
8
594
6082
12
0
596
6090
15
10
581
6055
8
15
508
5810
6
15
374
4565
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
1.0e+00
1.9e+00
3.0e+00
1.0e+50
3.3e+00
2.1e+00
9.7e-01
cases:8.06%
controls:3.07%
cases:12.34%
controls:1.99%
cases:5.10%
controls:0.26%
cases:1.15%
controls:0.00%
cases:7.89%
controls:0.33%
cases:14.34%
controls:2.09%
cases:16.58%
controls:7.01%
49
187
559
5903
75
121
533
5969
31
16
577
6074
7
0
601
6090
47
20
549
6045
74
122
442
5703
63
321
317
4259
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
1.1e+00
2.5e+00
—
1.0e+50
3.9e+00
2.6e+00
2.1e+00
cases:3.78%
controls:1.33%
cases:5.76%
controls:0.48%
—
—
cases:0.82%
controls:0.00%
cases:4.87%
controls:0.10%
cases:6.98%
controls:0.57%
cases:10.00%
controls:1.38%
23
81
585
6009
35
29
573
6061
—
5
0
603
6090
29
6
567
6059
36
33
480
5792
38
63
342
4517
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
57778-3 [40760888]
1.2e+00
2.1e+00
—
1.0e+50
3.5e+00
3.2e+00
2.0e+00
cases:1.97%
controls:0.57%
cases:2.96%
controls:0.36%
—
—
cases:1.15%
controls:0.00%
cases:3.19%
controls:0.10%
cases:5.62%
controls:0.24%
cases:6.05%
controls:0.83%
12
35
596
6055
18
22
590
6068
—
7
0
601
6090
19
6
577
6059
29
14
487
5811
23
38
357
4542
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
4.5e-01
1.8e+00
3.6e+00
1.0e+50
3.8e+00
2.0e+00
9.8e-01
cases:6.58%
controls:4.30%
cases:8.55%
controls:1.53%
cases:5.10%
controls:0.15%
cases:1.32%
controls:0.00%
cases:6.04%
controls:0.15%
cases:8.91%
controls:1.36%
cases:11.84%
controls:4.80%
40
262
568
5828
52
93
556
5997
31
9
577
6081
8
0
600
6090
36
9
560
6056
46
79
470
5746
45
220
335
4360
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
9.9e-01
2.0e+00
2.9e+00
—
3.2e+00
2.0e+00
9.7e-01
cases:8.39%
controls:3.28%
cases:13.32%
controls:2.10%
cases:5.43%
controls:0.33%
—
—
cases:7.72%
controls:0.33%
cases:14.73%
controls:2.18%
cases:17.11%
controls:7.25%
51
200
557
5890
81
128
527
5962
33
20
575
6070
—
46
20
550
6045
76
127
440
5698
65
332
315
4248
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
1.8e-01
1.1e+00
2.2e+00
5.0e+00
2.1e+00
9.6e-01
5.7e-01
cases:25.99%
controls:22.73%
cases:28.13%
controls:11.94%
cases:14.31%
controls:1.74%
cases:10.53%
controls:0.08%
cases:12.75%
controls:1.71%
cases:25.58%
controls:11.66%
cases:40.53%
controls:27.75%
158
1384
450
4706
171
727
437
5363
87
106
521
5984
64
5
544
6085
76
104
520
5961
132
679
384
5146
154
1271
226
3309
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
1.0e+00
2.0e+00
3.1e+00
1.0e+50
3.0e+00
1.7e+00
1.1e+00
cases:5.59%
controls:2.07%
cases:7.07%
controls:1.02%
cases:3.45%
controls:0.16%
cases:1.32%
controls:0.00%
cases:4.87%
controls:0.26%
cases:5.23%
controls:1.03%
cases:9.21%
controls:3.19%
34
126
574
5964
43
62
565
6028
21
10
587
6080
8
0
600
6090
29
16
567
6049
27
60
489
5765
35
146
345
4434
Nephrology
39 [38004479]
39 [38004479]
1.4e+00
1.6e+00
2.5e+00
—
2.7e+00
2.0e+00
1.5e+00
cases:4.77%
controls:1.17%
cases:4.61%
controls:0.92%
cases:2.96%
controls:0.25%
—
—
cases:4.36%
controls:0.31%
cases:5.62%
controls:0.82%
cases:5.53%
controls:1.24%
29
71
579
6019
28
56
580
6034
18
15
590
6075
—
26
19
570
6046
29
48
487
5777
21
57
359
4523
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
5.4e-01
1.2e+00
1.8e+00
4.2e+00
1.9e+00
1.2e+00
7.7e-01
cases:23.36%
controls:15.09%
cases:25.66%
controls:9.03%
cases:15.95%
controls:3.05%
cases:11.68%
controls:0.20%
cases:17.79%
controls:3.08%
cases:23.84%
controls:8.84%
cases:34.47%
controls:19.63%
142
919
466
5171
156
550
452
5540
97
186
511
5904
71
12
537
6078
106
187
490
5878
123
515
393
5310
131
899
249
3681
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
8.5e-01
1.8e+00
3.3e+00
1.0e+50
2.6e+00
1.7e+00
1.3e+00
cases:5.76%
controls:2.55%
cases:7.24%
controls:1.23%
cases:4.44%
controls:0.16%
cases:2.63%
controls:0.00%
cases:2.68%
controls:0.20%
cases:6.01%
controls:1.15%
cases:8.42%
controls:2.53%
35
155
573
5935
44
75
564
6015
27
10
581
6080
16
0
592
6090
16
12
580
6053
31
67
485
5758
32
116
348
4464
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
1.0e+00
1.6e+00
2.6e+00
1.0e+50
3.4e+00
1.8e+00
1.2e+00
cases:7.89%
controls:2.99%
cases:9.38%
controls:2.10%
cases:4.93%
controls:0.38%
cases:1.48%
controls:0.00%
cases:9.56%
controls:0.36%
cases:10.27%
controls:1.89%
cases:12.89%
controls:4.17%
48
182
560
5908
57
128
551
5962
30
23
578
6067
9
0
599
6090
57
22
539
6043
53
110
463
5715
49
191
331
4389
Cystostatic therapy of methastized malignancy
WD105 [2001310678]
WD105 [2001310678]
1.8e+00
2.5e+00
2.7e+00
—
2.3e+00
2.3e+00
—
cases:1.32%
controls:0.23%
cases:1.97%
controls:0.16%
cases:1.15%
controls:0.08%
—
—
cases:0.84%
controls:0.08%
cases:1.94%
controls:0.19%
—
—
8
14
600
6076
12
10
596
6080
7
5
601
6085
—
5
5
591
6060
10
11
506
5814
—
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
7.5e-01
1.6e+00
3.2e+00
—
3.2e+00
1.7e+00
1.1e+00
cases:11.18%
controls:5.62%
cases:11.68%
controls:2.61%
cases:5.92%
controls:0.26%
—
—
cases:5.54%
controls:0.23%
cases:10.85%
controls:2.21%
cases:17.63%
controls:6.90%
68
342
540
5748
71
159
537
5931
36
16
572
6074
—
33
14
563
6051
56
129
460
5696
67
316
313
4264
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
1.1e+00
1.8e+00
3.1e+00
1.0e+50
2.9e+00
1.5e+00
9.2e-01
cases:3.62%
controls:1.20%
cases:3.62%
controls:0.59%
cases:1.81%
controls:0.08%
cases:0.82%
controls:0.00%
cases:2.35%
controls:0.13%
cases:2.71%
controls:0.62%
cases:5.00%
controls:2.05%
22
73
586
6017
22
36
586
6054
11
5
597
6085
5
0
603
6090
14
8
582
6057
14
36
502
5789
19
94
361
4486
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.7e-01
8.7e-01
2.5e+00
3.5e+00
2.7e+00
1.2e+00
6.5e-01
cases:30.92%
controls:25.44%
cases:26.48%
controls:13.12%
cases:16.94%
controls:1.72%
cases:4.61%
controls:0.15%
cases:18.96%
controls:1.62%
cases:32.75%
controls:12.36%
cases:45.79%
controls:30.52%
188
1549
420
4541
161
799
447
5291
103
105
505
5985
28
9
580
6081
113
98
483
5967
169
720
347
5105
174
1398
206
3182
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
1.0e+00
1.9e+00
3.3e+00
—
3.6e+00
1.5e+00
6.5e-01
cases:7.24%
controls:2.79%
cases:7.40%
controls:1.13%
cases:2.96%
controls:0.11%
—
—
cases:5.03%
controls:0.15%
cases:5.81%
controls:1.30%
cases:7.37%
controls:4.00%
44
170
564
5920
45
69
563
6021
18
7
590
6083
—
30
9
566
6056
30
76
486
5749
28
183
352
4397
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
1.1e+00
1.8e+00
2.9e+00
1.0e+50
3.0e+00
1.4e+00
1.0e+00
cases:3.62%
controls:1.22%
cases:4.11%
controls:0.67%
cases:1.81%
controls:0.10%
cases:0.99%
controls:0.00%
cases:2.52%
controls:0.13%
cases:2.91%
controls:0.72%
cases:6.58%
controls:2.53%
22
74
586
6016
25
41
583
6049
11
6
597
6084
6
0
602
6090
15
8
581
6057
15
42
501
5783
25
116
355
4464
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
1.1e+00
1.8e+00
2.9e+00
1.0e+50
3.0e+00
1.4e+00
1.0e+00
cases:3.62%
controls:1.20%
cases:3.95%
controls:0.67%
cases:1.81%
controls:0.10%
cases:0.99%
controls:0.00%
cases:2.52%
controls:0.13%
cases:2.91%
controls:0.72%
cases:6.32%
controls:2.38%
22
73
586
6017
24
41
584
6049
11
6
597
6084
6
0
602
6090
15
8
581
6057
15
42
501
5783
24
109
356
4471
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
1.0e+00
1.5e+00
3.3e+00
—
2.7e+00
1.6e+00
1.1e+00
cases:3.29%
controls:1.22%
cases:4.44%
controls:1.07%
cases:3.29%
controls:0.13%
—
—
cases:5.20%
controls:0.36%
cases:5.43%
controls:1.12%
cases:9.47%
controls:3.23%
20
74
588
6016
27
65
581
6025
20
8
588
6082
—
31
22
565
6043
28
65
488
5760
36
148
344
4432
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
1.1e+00
1.5e+00
3.1e+00
—
2.5e+00
1.7e+00
1.2e+00
cases:3.95%
controls:1.40%
cases:4.61%
controls:1.07%
cases:3.13%
controls:0.15%
—
—
cases:4.70%
controls:0.40%
cases:5.23%
controls:1.01%
cases:10.00%
controls:3.14%
24
85
584
6005
28
65
580
6025
19
9
589
6081
—
28
24
568
6041
27
59
489
5766
38
144
342
4436
Medical Oncology
90 [38004507]
90 [38004507]
5.5e-01
1.1e+00
1.8e+00
3.7e+00
1.9e+00
1.2e+00
6.5e-01
cases:7.73%
controls:4.60%
cases:9.38%
controls:3.19%
cases:7.57%
controls:1.31%
cases:3.95%
controls:0.10%
cases:7.38%
controls:1.14%
cases:9.50%
controls:2.94%
cases:9.21%
controls:5.02%
47
280
561
5810
57
194
551
5896
46
80
562
6010
24
6
584
6084
44
69
552
5996
49
171
467
5654
35
230
345
4350
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
1.1e+00
1.5e+00
3.1e+00
—
2.5e+00
1.7e+00
1.2e+00
cases:4.11%
controls:1.44%
cases:4.77%
controls:1.10%
cases:3.13%
controls:0.15%
—
—
cases:4.70%
controls:0.40%
cases:5.43%
controls:1.08%
cases:10.53%
controls:3.32%
25
88
583
6002
29
67
579
6023
19
9
589
6081
—
28
24
568
6041
28
63
488
5762
40
152
340
4428
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
6.8e-01
2.0e+00
2.8e+00
—
3.3e+00
1.5e+00
7.7e-01
cases:6.91%
controls:3.61%
cases:8.22%
controls:1.23%
cases:3.13%
controls:0.20%
—
—
cases:4.19%
controls:0.16%
cases:5.43%
controls:1.25%
cases:10.00%
controls:4.91%
42
220
566
5870
50
75
558
6015
19
12
589
6078
—
25
10
571
6055
28
73
488
5752
38
225
342
4355
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
2.1e+00
2.8e+00
—
—
3.0e+00
2.9e+00
—
cases:1.64%
controls:0.21%
cases:1.64%
controls:0.10%
—
—
—
—
cases:1.68%
controls:0.08%
cases:2.13%
controls:0.12%
—
—
10
13
598
6077
10
6
598
6084
—
—
10
5
586
6060
11
7
505
5818
—
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
1.1e+00
1.4e+00
2.9e+00
—
2.5e+00
1.6e+00
1.2e+00
cases:3.78%
controls:1.33%
cases:4.28%
controls:1.05%
cases:2.63%
controls:0.15%
—
—
cases:4.19%
controls:0.36%
cases:5.23%
controls:1.06%
cases:9.21%
controls:3.08%
23
81
585
6009
26
64
582
6026
16
9
592
6081
—
25
22
571
6043
27
62
489
5763
35
141
345
4439
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
9.2e-01
1.6e+00
2.4e+00
1.0e+50
3.0e+00
1.8e+00
9.5e-01
cases:4.93%
controls:2.02%
cases:6.09%
controls:1.25%
cases:3.13%
controls:0.28%
cases:1.15%
controls:0.00%
cases:4.03%
controls:0.21%
cases:6.59%
controls:1.20%
cases:8.16%
controls:3.32%
30
123
578
5967
37
76
571
6014
19
17
589
6073
7
0
601
6090
24
13
572
6052
34
70
482
5755
31
152
349
4428
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
15189-4 [3007778]
1.1e+00
2.0e+00
—
1.0e+50
3.7e+00
3.1e+00
1.9e+00
cases:2.14%
controls:0.69%
cases:3.29%
controls:0.44%
—
—
cases:0.99%
controls:0.00%
cases:3.69%
controls:0.10%
cases:6.59%
controls:0.33%
cases:7.63%
controls:1.22%
13
42
595
6048
20
27
588
6063
—
6
0
602
6090
22
6
574
6059
34
19
482
5806
29
56
351
4524
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
7.1e-01
1.8e+00
2.9e+00
—
2.9e+00
1.7e+00
1.2e+00
cases:4.11%
controls:2.07%
cases:5.92%
controls:1.02%
cases:2.14%
controls:0.11%
—
—
cases:2.68%
controls:0.15%
cases:4.46%
controls:0.84%
cases:7.37%
controls:2.25%
25
126
583
5964
36
62
572
6028
13
7
595
6083
—
16
9
580
6056
23
49
493
5776
28
103
352
4477
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
3.7e-01
1.6e+00
2.8e+00
1.0e+50
4.0e+00
1.4e+00
7.7e-01
cases:5.26%
controls:3.69%
cases:6.41%
controls:1.41%
cases:2.30%
controls:0.15%
cases:1.32%
controls:0.00%
cases:4.36%
controls:0.08%
cases:5.62%
controls:1.41%
cases:8.42%
controls:4.08%
32
225
576
5865
39
86
569
6004
14
9
594
6081
8
0
600
6090
26
5
570
6060
29
82
487
5743
32
187
348
4393
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
2.9e-01
8.1e-01
2.1e+00
4.7e+00
2.0e+00
6.7e-01
2.5e-01
cases:50.99%
controls:43.89%
cases:48.36%
controls:29.51%
cases:29.28%
controls:4.94%
cases:22.86%
controls:0.28%
cases:29.36%
controls:5.18%
cases:43.22%
controls:28.09%
cases:58.16%
controls:51.88%
310
2673
298
3417
294
1797
314
4293
178
301
430
5789
139
17
469
6073
175
314
421
5751
223
1636
293
4189
221
2376
159
2204
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
3.8e-01
1.6e+00
2.6e+00
—
3.3e+00
2.0e+00
1.0e+00
cases:4.11%
controls:2.84%
cases:5.43%
controls:1.10%
cases:1.97%
controls:0.15%
—
—
cases:2.52%
controls:0.10%
cases:6.20%
controls:0.91%
cases:7.89%
controls:3.01%
25
173
583
5917
33
67
575
6023
12
9
596
6081
—
15
6
581
6059
32
53
484
5772
30
138
350
4442
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
7.2e-01
1.5e+00
2.7e+00
1.0e+50
3.7e+00
1.9e+00
7.4e-01
cases:3.45%
controls:1.71%
cases:4.93%
controls:1.18%
cases:1.97%
controls:0.13%
cases:0.82%
controls:0.00%
cases:4.36%
controls:0.12%
cases:6.01%
controls:0.96%
cases:7.89%
controls:3.93%
21
104
587
5986
30
72
578
6018
12
8
596
6082
5
0
603
6090
26
7
570
6058
31
56
485
5769
30
180
350
4400
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
7.5e-01
1.7e+00
3.1e+00
1.0e+50
2.6e+00
1.4e+00
9.3e-01
cases:8.88%
controls:4.42%
cases:8.39%
controls:1.64%
cases:4.77%
controls:0.23%
cases:3.29%
controls:0.00%
cases:3.36%
controls:0.25%
cases:6.78%
controls:1.80%
cases:14.74%
controls:6.38%
54
269
554
5821
51
100
557
5990
29
14
579
6076
20
0
588
6090
20
15
576
6050
35
105
481
5720
56
292
324
4288
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
5.3e-01
1.5e+00
3.6e+00
1.0e+50
3.2e+00
1.2e+00
5.3e-01
cases:13.49%
controls:8.37%
cases:14.47%
controls:3.63%
cases:7.73%
controls:0.23%
cases:5.10%
controls:0.00%
cases:6.21%
controls:0.28%
cases:9.50%
controls:3.21%
cases:17.11%
controls:10.81%
82
510
526
5580
88
221
520
5869
47
14
561
6076
31
0
577
6090
37
17
559
6048
49
187
467
5638
65
495
315
4085
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
7.9e-01
1.5e+00
3.2e+00
—
2.8e+00
1.4e+00
6.4e-01
cases:5.59%
controls:2.61%
cases:6.09%
controls:1.43%
cases:4.44%
controls:0.18%
—
—
cases:3.19%
controls:0.20%
cases:6.40%
controls:1.63%
cases:11.84%
controls:6.62%
34
159
574
5931
37
87
571
6003
27
11
581
6079
—
19
12
577
6053
33
95
483
5730
45
303
335
4277
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
2.1e-01
7.1e-01
2.1e+00
4.8e+00
2.2e+00
5.2e-01
1.2e-01
cases:50.99%
controls:45.63%
cases:53.29%
controls:35.96%
cases:37.01%
controls:6.85%
cases:34.05%
controls:0.44%
cases:37.75%
controls:6.41%
cases:49.42%
controls:36.79%
cases:62.37%
controls:59.41%
310
2779
298
3311
324
2190
284
3900
225
417
383
5673
207
27
401
6063
225
389
371
5676
255
2143
261
3682
237
2721
143
1859
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
5.7e-01
1.6e+00
2.9e+00
—
2.9e+00
1.4e+00
9.1e-01
cases:15.63%
controls:9.49%
cases:19.90%
controls:4.83%
cases:9.54%
controls:0.59%
—
—
cases:9.56%
controls:0.59%
cases:16.47%
controls:4.58%
cases:27.89%
controls:13.49%
95
578
513
5512
121
294
487
5796
58
36
550
6054
—
57
36
539
6029
85
267
431
5558
106
618
274
3962
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.9e-01
7.0e-01
2.1e+00
4.7e+00
2.2e+00
5.4e-01
1.5e-01
cases:50.82%
controls:45.98%
cases:53.62%
controls:36.45%
cases:37.17%
controls:6.90%
cases:34.05%
controls:0.46%
cases:37.92%
controls:6.56%
cases:50.19%
controls:37.12%
cases:63.16%
controls:59.69%
309
2800
299
3290
326
2220
282
3870
226
420
382
5670
207
28
401
6062
226
398
370
5667
259
2162
257
3663
240
2734
140
1846
Hematology
82 [38004501]
82 [38004501]
6.9e-01
1.4e+00
1.8e+00
1.0e+50
3.0e+00
2.2e+00
1.7e+00
cases:2.96%
controls:1.51%
cases:4.11%
controls:1.00%
cases:1.97%
controls:0.33%
cases:5.92%
controls:0.00%
cases:4.87%
controls:0.25%
cases:8.53%
controls:1.05%
cases:10.26%
controls:2.07%
18
92
590
5998
25
61
583
6029
12
20
596
6070
36
0
572
6090
29
15
567
6050
44
61
472
5764
39
95
341
4485
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
8.4e-01
1.5e+00
2.6e+00
1.0e+50
2.8e+00
1.5e+00
8.6e-01
cases:11.18%
controls:5.17%
cases:12.99%
controls:3.17%
cases:6.09%
controls:0.49%
cases:2.14%
controls:0.00%
cases:9.23%
controls:0.61%
cases:12.60%
controls:3.06%
cases:17.37%
controls:8.17%
68
315
540
5775
79
193
529
5897
37
30
571
6060
13
0
595
6090
55
37
541
6028
65
178
451
5647
66
374
314
4206
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
5.7e-01
1.5e+00
3.0e+00
—
2.8e+00
1.4e+00
8.3e-01
cases:13.32%
controls:8.01%
cases:17.93%
controls:4.52%
cases:9.21%
controls:0.51%
—
—
cases:9.23%
controls:0.59%
cases:15.31%
controls:4.43%
cases:25.00%
controls:12.71%
81
488
527
5602
109
275
499
5815
56
31
552
6059
—
55
36
541
6029
79
258
437
5567
95
582
285
3998
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
1.3e+00
2.0e+00
2.7e+00
1.0e+50
2.8e+00
1.2e+00
7.2e-01
cases:3.45%
controls:0.99%
cases:4.44%
controls:0.62%
cases:1.97%
controls:0.13%
cases:3.45%
controls:0.00%
cases:1.68%
controls:0.10%
cases:2.52%
controls:0.74%
cases:5.26%
controls:2.64%
21
60
587
6030
27
38
581
6052
12
8
596
6082
21
0
587
6090
10
6
586
6059
13
43
503
5782
20
121
360
4459
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
4.6e-01
1.5e+00
3.0e+00
—
2.9e+00
1.6e+00
1.1e+00
cases:9.38%
controls:6.14%
cases:10.86%
controls:2.58%
cases:5.59%
controls:0.30%
—
—
cases:5.87%
controls:0.33%
cases:9.30%
controls:2.13%
cases:15.26%
controls:5.87%
57
374
551
5716
66
157
542
5933
34
18
574
6072
—
35
20
561
6045
48
124
468
5701
58
269
322
4311
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
5.6e-01
1.6e+00
2.8e+00
1.0e+50
2.1e+00
1.9e+00
1.1e+00
cases:19.74%
controls:12.33%
cases:18.42%
controls:4.43%
cases:9.05%
controls:0.61%
cases:14.31%
controls:0.00%
cases:4.03%
controls:0.49%
cases:21.12%
controls:3.97%
cases:29.47%
controls:12.36%
120
751
488
5339
112
270
496
5820
55
37
553
6053
87
0
521
6090
24
30
572
6035
109
231
407
5594
112
566
268
4014
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
6.5e-01
1.5e+00
3.2e+00
—
2.9e+00
1.4e+00
9.8e-01
cases:5.26%
controls:2.81%
cases:4.11%
controls:0.92%
cases:1.97%
controls:0.08%
—
—
cases:2.01%
controls:0.12%
cases:3.68%
controls:0.93%
cases:7.63%
controls:3.01%
32
171
576
5919
25
56
583
6034
12
5
596
6085
—
12
7
584
6058
19
54
497
5771
29
138
351
4442
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
1.5e-01
6.1e-01
2.1e+00
4.6e+00
2.0e+00
5.5e-01
8.9e-02
cases:55.26%
controls:51.59%
cases:59.05%
controls:43.96%
cases:45.56%
controls:9.67%
cases:37.66%
controls:0.57%
cases:43.96%
controls:9.32%
cases:57.95%
controls:44.34%
cases:68.42%
controls:66.46%
336
3142
272
2948
359
2677
249
3413
277
589
331
5501
229
35
379
6055
262
565
334
5500
299
2583
217
3242
260
3044
120
1536
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
6.4e-01
1.9e+00
3.4e+00
1.0e+50
2.7e+00
1.3e+00
6.5e-01
cases:4.77%
controls:2.56%
cases:6.09%
controls:0.97%
cases:2.30%
controls:0.08%
cases:3.13%
controls:0.00%
cases:1.85%
controls:0.13%
cases:4.07%
controls:1.10%
cases:9.74%
controls:5.33%
29
156
579
5934
37
59
571
6031
14
5
594
6085
19
0
589
6090
11
8
585
6057
21
64
495
5761
37
244
343
4336
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.6e-01
6.1e-01
2.1e+00
4.6e+00
2.0e+00
5.5e-01
7.0e-02
cases:55.59%
controls:51.71%
cases:59.05%
controls:44.04%
cases:45.56%
controls:9.67%
cases:37.66%
controls:0.57%
cases:43.96%
controls:9.33%
cases:57.95%
controls:44.39%
cases:68.16%
controls:66.62%
338
3149
270
2941
359
2682
249
3408
277
589
331
5501
229
35
379
6055
262
566
334
5499
299
2586
217
3239
259
3051
121
1529
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
6.2e-01
1.3e+00
2.6e+00
1.0e+50
3.4e+00
1.8e+00
7.6e-01
cases:4.93%
controls:2.73%
cases:6.41%
controls:1.79%
cases:2.80%
controls:0.21%
cases:0.99%
controls:0.00%
cases:7.05%
controls:0.25%
cases:7.95%
controls:1.42%
cases:10.00%
controls:4.96%
30
166
578
5924
39
109
569
5981
17
13
591
6077
6
0
602
6090
42
15
554
6050
41
83
475
5742
38
227
342
4353
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.5e-01
6.0e-01
2.1e+00
4.6e+00
2.0e+00
5.5e-01
8.1e-02
cases:55.43%
controls:51.81%
cases:59.05%
controls:44.11%
cases:45.56%
controls:9.70%
cases:37.66%
controls:0.57%
cases:44.13%
controls:9.37%
cases:57.95%
controls:44.41%
cases:68.42%
controls:66.64%
337
3155
271
2935
359
2686
249
3404
277
591
331
5499
229
35
379
6055
263
568
333
5497
299
2587
217
3238
260
3052
120
1528
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
2.2e-01
6.4e-01
2.1e+00
4.6e+00
2.0e+00
5.5e-01
1.2e-01
cases:54.61%
controls:49.00%
cases:56.91%
controls:40.99%
cases:42.27%
controls:8.41%
cases:34.21%
controls:0.53%
cases:40.60%
controls:8.26%
cases:55.04%
controls:41.48%
cases:66.05%
controls:63.25%
332
2984
276
3106
346
2496
262
3594
257
512
351
5578
208
32
400
6058
242
501
354
5564
284
2416
232
3409
251
2897
129
1683
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.6e-01
6.1e-01
2.1e+00
4.6e+00
2.0e+00
5.5e-01
8.3e-02
cases:55.59%
controls:51.72%
cases:59.05%
controls:44.01%
cases:45.39%
controls:9.64%
cases:37.50%
controls:0.57%
cases:43.96%
controls:9.33%
cases:57.95%
controls:44.38%
cases:68.42%
controls:66.59%
338
3150
270
2940
359
2680
249
3410
276
587
332
5503
228
35
380
6055
262
566
334
5499
299
2585
217
3240
260
3050
120
1530
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
2.6e-01
6.5e-01
2.0e+00
4.6e+00
2.0e+00
6.0e-01
2.1e-01
cases:37.34%
controls:31.44%
cases:41.12%
controls:26.80%
cases:31.41%
controls:5.93%
cases:26.48%
controls:0.34%
cases:30.87%
controls:5.72%
cases:41.09%
controls:27.61%
cases:50.00%
controls:44.72%
227
1915
381
4175
250
1632
358
4458
191
361
417
5729
161
21
447
6069
184
347
412
5718
212
1608
304
4217
190
2048
190
2532
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
1.6e-01
6.1e-01
2.0e+00
4.6e+00
2.0e+00
5.5e-01
8.3e-02
cases:55.76%
controls:51.74%
cases:59.05%
controls:44.04%
cases:45.39%
controls:9.70%
cases:37.66%
controls:0.57%
cases:43.79%
controls:9.33%
cases:57.95%
controls:44.36%
cases:68.42%
controls:66.59%
339
3151
269
2939
359
2682
249
3408
276
591
332
5499
229
35
379
6055
261
566
335
5499
299
2584
217
3241
260
3050
120
1530
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
1.6e-01
5.9e-01
2.0e+00
4.6e+00
2.0e+00
5.6e-01
8.1e-02
cases:55.59%
controls:51.71%
cases:58.72%
controls:44.02%
cases:45.39%
controls:9.67%
cases:37.66%
controls:0.57%
cases:43.79%
controls:9.33%
cases:58.14%
controls:44.36%
cases:68.42%
controls:66.64%
338
3149
270
2941
357
2681
251
3409
276
589
332
5501
229
35
379
6055
261
566
335
5499
300
2584
216
3241
260
3052
120
1528
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
1.6e-01
6.0e-01
2.0e+00
4.6e+00
2.0e+00
5.5e-01
7.1e-02
cases:55.59%
controls:51.66%
cases:58.72%
controls:43.96%
cases:45.23%
controls:9.64%
cases:37.50%
controls:0.57%
cases:43.79%
controls:9.32%
cases:57.95%
controls:44.36%
cases:68.16%
controls:66.59%
338
3146
270
2944
357
2677
251
3413
275
587
333
5503
228
35
380
6055
261
565
335
5500
299
2584
217
3241
259
3050
121
1530
Fractional oxyhemoglobin in Capillary blood
2715-1 [3022806]
2715-1 [3022806]
2.1e+00
3.0e+00
1.0e+50
—
—
2.6e+00
2.1e+00
cases:2.14%
controls:0.26%
cases:1.64%
controls:0.08%
cases:1.15%
controls:0.00%
—
—
—
—
cases:1.55%
controls:0.12%
cases:1.84%
controls:0.22%
13
16
595
6074
10
5
598
6085
7
0
601
6090
—
—
8
7
508
5818
7
10
373
4570
tinzaparin; parenteral
B01AB10 [21600981]
B01AB10 [21600981]
1.1e+00
1.2e+00
2.0e+00
—
2.6e+00
2.0e+00
9.3e-01
cases:3.62%
controls:1.23%
cases:2.63%
controls:0.80%
cases:1.32%
controls:0.18%
—
—
cases:1.34%
controls:0.10%
cases:2.91%
controls:0.41%
cases:4.47%
controls:1.81%
22
75
586
6015
16
49
592
6041
8
11
600
6079
—
8
6
588
6059
15
24
501
5801
17
83
363
4497
Internal Medicine
11 [38004456]
11 [38004456]
5.1e-01
1.4e+00
2.7e+00
—
2.6e+00
1.8e+00
8.8e-01
cases:35.03%
controls:24.52%
cases:29.11%
controls:9.16%
cases:15.63%
controls:1.26%
—
—
cases:16.11%
controls:1.45%
cases:35.66%
controls:8.38%
cases:39.21%
controls:21.18%
213
1493
395
4597
177
558
431
5532
95
77
513
6013
—
96
88
500
5977
184
488
332
5337
149
970
231
3610
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.8e-01
6.4e-01
2.1e+00
4.5e+00
2.0e+00
6.0e-01
1.8e-01
cases:38.65%
controls:34.55%
cases:44.41%
controls:29.72%
cases:33.55%
controls:6.03%
cases:25.33%
controls:0.36%
cases:31.88%
controls:6.02%
cases:43.80%
controls:30.06%
cases:54.47%
controls:49.93%
235
2104
373
3986
270
1810
338
4280
204
367
404
5723
154
22
454
6068
190
365
406
5700
226
1751
290
4074
207
2287
173
2293
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
7.0e-01
1.7e+00
2.2e+00
1.0e+50
2.5e+00
2.1e+00
1.4e+00
cases:3.45%
controls:1.74%
cases:3.13%
controls:0.61%
cases:0.99%
controls:0.11%
cases:2.63%
controls:0.00%
cases:1.34%
controls:0.12%
cases:3.10%
controls:0.39%
cases:3.42%
controls:0.85%
21
106
587
5984
19
37
589
6053
6
7
602
6083
16
0
592
6090
8
7
588
6058
16
23
500
5802
13
39
367
4541
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
3.4e-01
1.9e+00
2.5e+00
—
3.6e+00
1.7e+00
6.1e-01
cases:1.32%
controls:0.94%
cases:3.95%
controls:0.59%
cases:0.99%
controls:0.08%
—
—
cases:2.85%
controls:0.08%
cases:2.71%
controls:0.50%
cases:3.68%
controls:2.03%
8
57
600
6033
24
36
584
6054
6
5
602
6085
—
17
5
579
6060
14
29
502
5796
14
93
366
4487
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
6.1e-01
1.6e+00
2.9e+00
—
3.0e+00
1.2e+00
4.4e-01
cases:10.53%
controls:6.03%
cases:16.45%
controls:3.96%
cases:9.05%
controls:0.53%
—
—
cases:9.06%
controls:0.49%
cases:13.18%
controls:4.50%
cases:21.84%
controls:15.24%
64
367
544
5723
100
241
508
5849
55
32
553
6058
—
54
30
542
6035
68
262
448
5563
83
698
297
3882
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.1e-01
1.5e+00
2.6e+00
—
3.0e+00
1.4e+00
7.7e-01
cases:21.55%
controls:14.14%
cases:27.14%
controls:7.93%
cases:17.93%
controls:1.61%
—
—
cases:23.83%
controls:1.58%
cases:25.97%
controls:7.93%
cases:34.21%
controls:19.39%
131
861
477
5229
165
483
443
5607
109
98
499
5992
—
142
96
454
5969
134
462
382
5363
130
888
250
3692
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
2.0e-01
7.5e-01
2.0e+00
4.4e+00
2.0e+00
6.0e-01
2.1e-01
cases:51.15%
controls:46.12%
cases:53.29%
controls:35.07%
cases:32.24%
controls:6.24%
cases:16.45%
controls:0.25%
cases:32.38%
controls:6.08%
cases:50.39%
controls:35.73%
cases:65.53%
controls:60.61%
311
2809
297
3281
324
2136
284
3954
196
380
412
5710
100
15
508
6075
193
369
403
5696
260
2081
256
3744
249
2776
131
1804
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
1.3e+00
1.9e+00
3.4e+00
1.0e+50
—
1.9e+00
1.2e+00
cases:4.11%
controls:1.13%
cases:4.28%
controls:0.64%
cases:2.30%
controls:0.08%
cases:0.99%
controls:0.00%
—
—
cases:4.07%
controls:0.62%
cases:6.58%
controls:2.16%
25
69
583
6021
26
39
582
6051
14
5
594
6085
6
0
602
6090
—
21
36
495
5789
25
99
355
4481
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
6.2e-01
1.4e+00
2.5e+00
—
2.9e+00
1.5e+00
6.1e-01
cases:13.32%
controls:7.67%
cases:15.30%
controls:4.27%
cases:9.05%
controls:0.79%
—
—
cases:14.60%
controls:0.94%
cases:17.25%
controls:4.33%
cases:20.00%
controls:11.92%
81
467
527
5623
93
260
515
5830
55
48
553
6042
—
87
57
509
6008
89
252
427
5573
76
546
304
4034
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
5.3e-01
1.3e+00
3.0e+00
—
2.6e+00
1.3e+00
9.1e-01
cases:11.02%
controls:6.78%
cases:12.66%
controls:3.66%
cases:7.07%
controls:0.39%
—
—
cases:6.21%
controls:0.51%
cases:11.63%
controls:3.55%
cases:21.58%
controls:10.00%
67
413
541
5677
77
223
531
5867
43
24
565
6066
—
37
31
559
6034
60
207
456
5618
82
458
298
4122
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.7e-01
1.4e+00
2.7e+00
—
2.8e+00
1.5e+00
7.0e-01
cases:18.75%
controls:12.59%
cases:22.53%
controls:6.62%
cases:13.98%
controls:1.13%
—
—
cases:18.12%
controls:1.32%
cases:23.84%
controls:6.49%
cases:30.79%
controls:18.08%
114
767
494
5323
137
403
471
5687
85
69
523
6021
—
108
80
488
5985
123
378
393
5447
117
828
263
3752
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
5.4e-01
1.4e+00
2.9e+00
—
2.8e+00
1.3e+00
6.7e-01
cases:14.47%
controls:9.00%
cases:18.59%
controls:5.29%
cases:10.03%
controls:0.64%
—
—
cases:10.07%
controls:0.68%
cases:17.25%
controls:5.48%
cases:26.05%
controls:15.26%
88
548
520
5542
113
322
495
5768
61
39
547
6051
—
60
41
536
6024
89
319
427
5506
99
699
281
3881
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
5.4e-01
1.4e+00
2.9e+00
—
2.5e+00
1.3e+00
9.0e-01
cases:11.84%
controls:7.24%
cases:13.98%
controls:3.96%
cases:7.57%
controls:0.46%
—
—
cases:6.38%
controls:0.56%
cases:12.79%
controls:3.76%
cases:22.63%
controls:10.63%
72
441
536
5649
85
241
523
5849
46
28
562
6062
—
38
34
558
6031
66
219
450
5606
86
487
294
4093
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
1.1e+00
1.7e+00
—
1.0e+50
3.4e+00
2.3e+00
1.0e+00
cases:4.77%
controls:1.71%
cases:3.95%
controls:0.77%
—
—
cases:3.62%
controls:0.00%
cases:2.52%
controls:0.08%
cases:5.43%
controls:0.58%
cases:6.32%
controls:2.36%
29
104
579
5986
24
47
584
6043
—
22
0
586
6090
15
5
581
6060
28
34
488
5791
24
108
356
4472
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
4.4e-01
1.3e+00
2.5e+00
—
2.8e+00
1.5e+00
9.4e-01
cases:20.39%
controls:14.20%
cases:24.84%
controls:8.51%
cases:15.46%
controls:1.43%
—
—
cases:19.30%
controls:1.45%
cases:27.52%
controls:8.07%
cases:36.32%
controls:18.17%
124
865
484
5225
151
518
457
5572
94
87
514
6003
—
115
88
481
5977
142
470
374
5355
138
832
242
3748
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
4.4e-01
1.3e+00
2.5e+00
—
2.8e+00
1.5e+00
9.5e-01
cases:20.39%
controls:14.22%
cases:24.84%
controls:8.52%
cases:15.30%
controls:1.43%
—
—
cases:18.96%
controls:1.47%
cases:27.52%
controls:8.05%
cases:36.32%
controls:18.10%
124
866
484
5224
151
519
457
5571
93
87
515
6003
—
113
89
483
5976
142
469
374
5356
138
829
242
3751
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
9.9e-01
1.5e+00
2.6e+00
1.0e+50
2.5e+00
1.8e+00
5.4e-01
cases:5.92%
controls:2.28%
cases:5.26%
controls:1.20%
cases:2.80%
controls:0.21%
cases:4.28%
controls:0.00%
cases:3.36%
controls:0.28%
cases:7.56%
controls:1.39%
cases:7.89%
controls:4.74%
36
139
572
5951
32
73
576
6017
17
13
591
6077
26
0
582
6090
20
17
576
6048
39
81
477
5744
30
217
350
4363
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
1.2e+00
2.0e+00
—
1.0e+50
2.6e+00
2.1e+00
1.4e+00
cases:6.58%
controls:2.04%
cases:4.44%
controls:0.61%
—
—
cases:3.78%
controls:0.00%
cases:1.51%
controls:0.12%
cases:3.49%
controls:0.43%
cases:6.84%
controls:1.79%
40
124
568
5966
27
37
581
6053
—
23
0
585
6090
9
7
587
6058
18
25
498
5800
26
82
354
4498
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
4.0e-01
1.3e+00
2.5e+00
—
2.8e+00
1.4e+00
9.3e-01
cases:19.74%
controls:14.15%
cases:24.51%
controls:8.49%
cases:15.63%
controls:1.43%
—
—
cases:19.13%
controls:1.47%
cases:27.33%
controls:8.12%
cases:36.32%
controls:18.30%
120
862
488
5228
149
517
459
5573
95
87
513
6003
—
114
89
482
5976
141
473
375
5352
138
838
242
3742
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
8.5e-01
1.6e+00
2.6e+00
—
3.1e+00
1.2e+00
4.2e-01
cases:4.61%
controls:2.02%
cases:5.59%
controls:1.18%
cases:2.30%
controls:0.18%
—
—
cases:2.18%
controls:0.10%
cases:4.26%
controls:1.30%
cases:8.68%
controls:5.90%
28
123
580
5967
34
72
574
6018
14
11
594
6079
—
13
6
583
6059
22
76
494
5749
33
270
347
4310
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
4.8e-01
1.3e+00
2.4e+00
—
2.8e+00
1.5e+00
8.6e-01
cases:21.88%
controls:14.76%
cases:25.99%
controls:8.92%
cases:15.46%
controls:1.59%
—
—
cases:20.64%
controls:1.50%
cases:29.65%
controls:8.93%
cases:37.63%
controls:20.39%
133
899
475
5191
158
543
450
5547
94
97
514
5993
—
123
91
473
5974
153
520
363
5305
143
934
237
3646
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
6.2e-01
1.6e+00
3.5e+00
1.0e+50
2.6e+00
1.6e+00
6.5e-01
cases:3.45%
controls:1.89%
cases:4.44%
controls:0.95%
cases:3.78%
controls:0.11%
cases:2.47%
controls:0.00%
cases:2.01%
controls:0.15%
cases:5.62%
controls:1.20%
cases:8.42%
controls:4.59%
21
115
587
5975
27
58
581
6032
23
7
585
6083
15
0
593
6090
12
9
584
6056
29
70
487
5755
32
210
348
4370
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
4.2e-01
1.3e+00
2.5e+00
—
2.9e+00
1.4e+00
8.3e-01
cases:21.71%
controls:15.35%
cases:26.48%
controls:9.18%
cases:16.12%
controls:1.61%
—
—
cases:22.15%
controls:1.55%
cases:29.84%
controls:9.24%
cases:37.89%
controls:20.94%
132
935
476
5155
161
559
447
5531
98
98
510
5992
—
132
94
464
5971
154
538
362
5287
144
959
236
3621
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
4.6e-01
1.3e+00
2.4e+00
—
2.8e+00
1.5e+00
8.6e-01
cases:21.55%
controls:14.73%
cases:25.99%
controls:8.90%
cases:15.46%
controls:1.59%
—
—
cases:20.47%
controls:1.50%
cases:29.46%
controls:8.88%
cases:37.63%
controls:20.28%
131
897
477
5193
158
542
450
5548
94
97
514
5993
—
122
91
474
5974
152
517
364
5308
143
929
237
3651
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
4.2e-01
1.3e+00
2.5e+00
—
2.7e+00
1.4e+00
8.9e-01
cases:20.39%
controls:14.38%
cases:25.16%
controls:8.72%
cases:15.46%
controls:1.44%
—
—
cases:19.30%
controls:1.52%
cases:27.71%
controls:8.34%
cases:36.32%
controls:18.93%
124
876
484
5214
153
531
455
5559
94
88
514
6002
—
115
92
481
5973
143
486
373
5339
138
867
242
3713
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
3.4e-01
1.2e+00
2.6e+00
—
2.9e+00
1.5e+00
1.1e+00
cases:13.65%
controls:10.15%
cases:17.93%
controls:6.04%
cases:11.68%
controls:0.99%
—
—
cases:14.93%
controls:0.94%
cases:20.93%
controls:5.80%
cases:28.42%
controls:12.03%
83
618
525
5472
109
368
499
5722
71
60
537
6030
—
89
57
507
6008
108
338
408
5487
108
551
272
4029
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
19239-3 [3028271]
2.1e+00
3.2e+00
—
—
—
2.2e+00
1.7e+00
cases:2.14%
controls:0.26%
cases:1.97%
controls:0.08%
—
—
—
—
—
—
cases:1.74%
controls:0.19%
cases:2.89%
controls:0.57%
13
16
595
6074
12
5
596
6085
—
—
—
9
11
507
5814
11
26
369
4554
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
4.4e-01
1.3e+00
2.4e+00
—
2.8e+00
1.4e+00
8.5e-01
cases:22.20%
controls:15.47%
cases:26.97%
controls:9.24%
cases:15.63%
controls:1.66%
—
—
cases:20.47%
controls:1.55%
cases:29.65%
controls:9.30%
cases:38.42%
controls:21.00%
135
942
473
5148
164
563
444
5527
95
101
513
5989
—
122
94
474
5971
153
542
363
5283
146
962
234
3618
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
6.1e-01
1.5e+00
2.6e+00
1.0e+50
2.5e+00
1.3e+00
6.7e-01
cases:9.21%
controls:5.22%
cases:6.58%
controls:1.51%
cases:2.96%
controls:0.23%
cases:0.82%
controls:0.00%
cases:2.52%
controls:0.21%
cases:5.23%
controls:1.49%
cases:11.58%
controls:6.27%
56
318
552
5772
40
92
568
5998
18
14
590
6076
5
0
603
6090
15
13
581
6052
27
87
489
5738
44
287
336
4293
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
9.7e-01
9.5e-01
2.8e+00
—
3.1e+00
1.5e+00
7.5e-01
cases:6.58%
controls:2.61%
cases:2.30%
controls:0.90%
cases:1.64%
controls:0.10%
—
—
cases:2.52%
controls:0.12%
cases:5.04%
controls:1.17%
cases:6.84%
controls:3.36%
40
159
568
5931
14
55
594
6035
10
6
598
6084
—
15
7
581
6058
26
68
490
5757
26
154
354
4426
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
6.3e-01
1.5e+00
2.0e+00
1.0e+50
2.3e+00
1.6e+00
1.1e+00
cases:13.49%
controls:7.68%
cases:7.24%
controls:1.72%
cases:1.15%
controls:0.16%
cases:1.81%
controls:0.00%
cases:1.51%
controls:0.15%
cases:6.01%
controls:1.29%
cases:12.11%
controls:4.21%
82
468
526
5622
44
105
564
5985
7
10
601
6080
11
0
597
6090
9
9
587
6056
31
75
485
5750
46
193
334
4387
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
1.3e+00
1.6e+00
1.8e+00
—
2.1e+00
1.5e+00
8.4e-01
cases:6.74%
controls:2.00%
cases:6.25%
controls:1.38%
cases:3.29%
controls:0.54%
—
—
cases:4.36%
controls:0.56%
cases:6.98%
controls:1.61%
cases:10.26%
controls:4.69%
41
122
567
5968
38
84
570
6006
20
33
588
6057
—
26
34
570
6031
36
94
480
5731
39
215
341
4365
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
1.6e+00
2.6e+00
—
—
—
2.8e+00
2.0e+00
cases:1.81%
controls:0.36%
cases:1.97%
controls:0.15%
—
—
—
—
—
—
cases:3.10%
controls:0.19%
cases:3.68%
controls:0.50%
11
22
597
6068
12
9
596
6081
—
—
—
16
11
500
5814
14
23
366
4557
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
7.5e-01
1.5e+00
3.5e+00
1.0e+50
2.6e+00
1.5e+00
6.1e-01
cases:3.78%
controls:1.82%
cases:4.44%
controls:1.03%
cases:3.62%
controls:0.11%
cases:2.63%
controls:0.00%
cases:2.18%
controls:0.16%
cases:5.43%
controls:1.29%
cases:8.68%
controls:4.91%
23
111
585
5979
27
63
581
6027
22
7
586
6083
16
0
592
6090
13
10
583
6055
28
75
488
5750
33
225
347
4355
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
4.0e-01
1.2e+00
2.5e+00
—
2.7e+00
1.4e+00
9.1e-01
cases:19.41%
controls:13.94%
cases:23.19%
controls:8.44%
cases:14.64%
controls:1.41%
—
—
cases:17.95%
controls:1.45%
cases:26.16%
controls:8.15%
cases:35.79%
controls:18.38%
118
849
490
5241
141
514
467
5576
89
86
519
6004
—
107
88
489
5977
135
475
381
5350
136
842
244
3738
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
5.7e-01
9.8e-01
2.4e+00
—
3.1e+00
1.2e+00
7.9e-01
cases:12.34%
controls:7.36%
cases:8.22%
controls:3.27%
cases:3.78%
controls:0.36%
—
—
cases:6.38%
controls:0.31%
cases:8.91%
controls:2.73%
cases:17.63%
controls:8.82%
75
448
533
5642
50
199
558
5891
23
22
585
6068
—
38
19
558
6046
46
159
470
5666
67
404
313
4176
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
6.6e-01
1.3e+00
2.0e+00
1.0e+50
2.9e+00
1.4e+00
7.0e-01
cases:11.84%
controls:6.47%
cases:13.49%
controls:3.89%
cases:3.78%
controls:0.51%
cases:1.32%
controls:0.00%
cases:7.38%
controls:0.45%
cases:12.79%
controls:3.43%
cases:19.47%
controls:10.72%
72
394
536
5696
82
237
526
5853
23
31
585
6059
8
0
600
6090
44
27
552
6038
66
200
450
5625
74
491
306
4089
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
8.2e-01
1.4e+00
2.0e+00
1.0e+50
2.5e+00
1.4e+00
9.2e-01
cases:5.10%
controls:2.32%
cases:4.93%
controls:1.30%
cases:1.64%
controls:0.23%
cases:0.82%
controls:0.00%
cases:2.01%
controls:0.16%
cases:4.65%
controls:1.20%
cases:7.11%
controls:2.95%
31
141
577
5949
30
79
578
6011
10
14
598
6076
5
0
603
6090
12
10
584
6055
24
70
492
5755
27
135
353
4445
General Practice
1 [38004446]
1 [38004446]
5.5e-01
1.4e+00
2.7e+00
—
2.7e+00
1.1e+00
5.2e-01
cases:25.66%
controls:16.58%
cases:21.05%
controls:5.94%
cases:10.03%
controls:0.72%
—
—
cases:12.08%
controls:0.94%
cases:18.60%
controls:7.14%
cases:29.47%
controls:19.93%
156
1010
452
5080
128
362
480
5728
61
44
547
6046
—
72
57
524
6008
96
416
420
5409
112
913
268
3667
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
4.0e-01
1.5e+00
3.1e+00
1.0e+50
3.2e+00
1.2e+00
3.1e-01
cases:2.30%
controls:1.56%
cases:3.78%
controls:0.89%
cases:2.14%
controls:0.10%
cases:2.14%
controls:0.00%
cases:2.35%
controls:0.10%
cases:3.49%
controls:1.10%
cases:5.53%
controls:4.13%
14
95
594
5995
23
54
585
6036
13
6
595
6084
13
0
595
6090
14
6
582
6059
18
64
498
5761
21
189
359
4391
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
4.8e-01
1.3e+00
2.3e+00
—
2.8e+00
1.4e+00
6.5e-01
cases:20.72%
controls:13.97%
cases:23.36%
controls:7.52%
cases:12.34%
controls:1.33%
—
—
cases:18.96%
controls:1.45%
cases:24.81%
controls:7.73%
cases:33.68%
controls:20.96%
126
851
482
5239
142
458
466
5632
75
81
533
6009
—
113
88
483
5977
128
450
388
5375
128
960
252
3620
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
6.0e-01
1.4e+00
2.3e+00
1.0e+50
2.5e+00
1.4e+00
6.9e-01
cases:17.27%
controls:10.31%
cases:22.37%
controls:6.90%
cases:9.21%
controls:0.97%
cases:2.30%
controls:0.00%
cases:9.73%
controls:0.86%
cases:22.09%
controls:6.54%
cases:31.58%
controls:18.86%
105
628
503
5462
136
420
472
5670
56
59
552
6031
14
0
594
6090
58
52
538
6013
114
381
402
5444
120
864
260
3716
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
5.2e-01
1.3e+00
2.9e+00
1.0e+50
2.5e+00
1.3e+00
4.7e-01
cases:12.66%
controls:7.95%
cases:14.31%
controls:4.50%
cases:8.55%
controls:0.51%
cases:6.58%
controls:0.00%
cases:7.38%
controls:0.68%
cases:14.34%
controls:4.50%
cases:18.42%
controls:12.36%
77
484
531
5606
87
274
521
5816
52
31
556
6059
40
0
568
6090
44
41
552
6024
74
262
442
5563
70
566
310
4014
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
6.6e-01
1.1e+00
2.8e+00
—
3.1e+00
1.1e+00
2.6e-01
cases:14.14%
controls:7.82%
cases:12.17%
controls:4.22%
cases:6.74%
controls:0.44%
—
—
cases:9.06%
controls:0.43%
cases:12.98%
controls:4.55%
cases:18.16%
controls:14.61%
86
476
522
5614
74
257
534
5833
41
27
567
6063
—
54
26
542
6039
67
265
449
5560
69
669
311
3911
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
5.0e-01
1.2e+00
2.1e+00
—
2.7e+00
1.6e+00
7.8e-01
cases:14.80%
controls:9.54%
cases:7.24%
controls:2.33%
cases:2.80%
controls:0.34%
—
—
cases:5.03%
controls:0.36%
cases:9.69%
controls:2.09%
cases:11.32%
controls:5.55%
90
581
518
5509
44
142
564
5948
17
21
591
6069
—
30
22
566
6043
50
122
466
5703
43
254
337
4326
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
4.6e-01
1.8e+00
2.7e+00
1.0e+50
2.2e+00
1.5e+00
8.0e-01
cases:2.63%
controls:1.67%
cases:4.44%
controls:0.79%
cases:1.15%
controls:0.08%
cases:3.62%
controls:0.00%
cases:1.01%
controls:0.12%
cases:3.10%
controls:0.74%
cases:6.05%
controls:2.82%
16
102
592
5988
27
48
581
6042
7
5
601
6085
22
0
586
6090
6
7
590
6058
16
43
500
5782
23
129
357
4451
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
5.5e-01
1.3e+00
2.6e+00
1.0e+50
2.7e+00
1.3e+00
8.1e-01
cases:6.09%
controls:3.60%
cases:4.28%
controls:1.20%
cases:1.97%
controls:0.15%
cases:1.32%
controls:0.00%
cases:1.85%
controls:0.13%
cases:4.46%
controls:1.25%
cases:8.68%
controls:4.06%
37
219
571
5871
26
73
582
6017
12
9
596
6081
8
0
600
6090
11
8
585
6057
23
73
493
5752
33
186
347
4394
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
3.6e-01
1.4e+00
2.6e+00
1.0e+50
3.2e+00
1.3e+00
2.5e-01
cases:2.63%
controls:1.86%
cases:4.28%
controls:1.13%
cases:2.47%
controls:0.18%
cases:2.30%
controls:0.00%
cases:2.85%
controls:0.12%
cases:4.84%
controls:1.32%
cases:6.05%
controls:4.78%
16
113
592
5977
26
69
582
6021
15
11
593
6079
14
0
594
6090
17
7
579
6058
25
77
491
5748
23
219
357
4361
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
2.4e-01
6.7e-01
1.2e+00
4.7e+00
1.5e+00
4.8e-01
1.7e-01
cases:29.11%
controls:24.45%
cases:21.88%
controls:12.55%
cases:6.41%
controls:2.09%
cases:8.55%
controls:0.08%
cases:9.06%
controls:2.18%
cases:19.57%
controls:13.10%
cases:35.79%
controls:31.88%
177
1489
431
4601
133
764
475
5326
39
127
569
5963
52
5
556
6085
54
132
542
5933
101
763
415
5062
136
1460
244
3120
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.1e-01
4.0e-01
1.7e+00
4.5e+00
1.6e+00
3.7e-01
4.0e-02
cases:58.72%
controls:55.98%
cases:61.84%
controls:52.07%
cases:52.47%
controls:17.04%
cases:42.43%
controls:0.84%
cases:50.67%
controls:16.90%
cases:62.60%
controls:53.55%
cases:71.84%
controls:71.03%
357
3409
251
2681
376
3171
232
2919
319
1038
289
5052
258
51
350
6039
302
1025
294
5040
323
3119
193
2706
273
3253
107
1327
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
1.7e+00
2.0e+00
2.8e+00
—
—
2.0e+00
2.0e+00
cases:1.32%
controls:0.25%
cases:1.48%
controls:0.20%
cases:1.32%
controls:0.08%
—
—
—
—
cases:1.55%
controls:0.21%
cases:1.32%
controls:0.17%
8
15
600
6075
9
12
599
6078
8
5
600
6085
—
—
8
12
508
5813
5
8
375
4572
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
87975-9 [36305247]
2.1e+00
2.5e+00
—
—
—
2.4e+00
1.6e+00
cases:3.29%
controls:0.43%
cases:2.80%
controls:0.25%
—
—
—
—
—
—
cases:2.52%
controls:0.24%
cases:3.16%
controls:0.63%
20
26
588
6064
17
15
591
6075
—
—
—
13
14
503
5811
12
29
368
4551
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
4.2e-01
1.5e+00
3.0e+00
—
2.5e+00
1.1e+00
4.1e-01
cases:16.45%
controls:11.44%
cases:17.93%
controls:4.73%
cases:8.39%
controls:0.48%
—
—
cases:8.56%
controls:0.74%
cases:14.15%
controls:5.18%
cases:22.37%
controls:16.07%
100
697
508
5393
109
288
499
5802
51
29
557
6061
—
51
45
545
6020
73
302
443
5523
85
736
295
3844
Emergency Room Visit
ER [9203]
ER [9203]
4.6e-01
1.5e+00
2.5e+00
—
2.2e+00
1.1e+00
7.1e-01
cases:48.52%
controls:37.24%
cases:37.50%
controls:11.94%
cases:16.61%
controls:1.54%
—
—
cases:11.58%
controls:1.48%
cases:26.94%
controls:10.94%
cases:46.84%
controls:30.20%
295
2268
313
3822
228
727
380
5363
101
94
507
5996
—
69
90
527
5975
139
637
377
5188
178
1383
202
3197
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
4.9e-01
1.1e+00
2.6e+00
1.0e+50
2.5e+00
1.1e+00
5.0e-01
cases:11.84%
controls:7.60%
cases:9.21%
controls:3.14%
cases:4.44%
controls:0.33%
cases:2.80%
controls:0.00%
cases:4.53%
controls:0.38%
cases:8.53%
controls:2.94%
cases:17.11%
controls:11.11%
72
463
536
5627
56
191
552
5899
27
20
581
6070
17
0
591
6090
27
23
569
6042
44
171
472
5654
65
509
315
4071
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
64799-0 [40767503]
2.0e+00
2.9e+00
—
—
—
1.9e+00
1.6e+00
cases:2.30%
controls:0.31%
cases:2.63%
controls:0.15%
—
—
—
—
—
—
cases:1.94%
controls:0.31%
cases:3.68%
controls:0.79%
14
19
594
6071
16
9
592
6081
—
—
—
10
18
506
5807
14
36
366
4544
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
1.1e+00
1.8e+00
—
—
2.5e+00
2.2e+00
1.9e+00
cases:1.97%
controls:0.66%
cases:1.81%
controls:0.30%
—
—
—
—
cases:1.17%
controls:0.10%
cases:3.88%
controls:0.46%
cases:4.74%
controls:0.76%
12
40
596
6050
11
18
597
6072
—
—
7
6
589
6059
20
27
496
5798
18
35
362
4545
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
3.5e-01
1.4e+00
2.5e+00
1.0e+50
3.0e+00
1.4e+00
3.3e-01
cases:2.63%
controls:1.87%
cases:4.44%
controls:1.15%
cases:2.47%
controls:0.20%
cases:2.14%
controls:0.00%
cases:2.52%
controls:0.13%
cases:5.23%
controls:1.34%
cases:6.58%
controls:4.83%
16
114
592
5976
27
70
581
6020
15
12
593
6078
13
0
595
6090
15
8
581
6057
27
78
489
5747
25
221
355
4359
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
FM1EE [2001303307]
6.6e-01
1.4e+00
2.2e+00
1.0e+50
2.0e+00
1.3e+00
7.4e-01
cases:9.87%
controls:5.37%
cases:7.89%
controls:2.13%
cases:1.81%
controls:0.20%
cases:2.30%
controls:0.00%
cases:1.68%
controls:0.23%
cases:6.78%
controls:1.92%
cases:13.16%
controls:6.75%
60
327
548
5763
48
130
560
5960
11
12
597
6078
14
0
594
6090
10
14
586
6051
35
112
481
5713
50
309
330
4271
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
3.0e-01
1.3e+00
2.6e+00
1.0e+50
3.0e+00
1.4e+00
2.2e-01
cases:2.47%
controls:1.84%
cases:3.95%
controls:1.13%
cases:2.63%
controls:0.20%
cases:2.14%
controls:0.00%
cases:2.52%
controls:0.13%
cases:4.84%
controls:1.25%
cases:5.79%
controls:4.69%
15
112
593
5978
24
69
584
6021
16
12
592
6078
13
0
595
6090
15
8
581
6057
25
73
491
5752
22
215
358
4365
Pleural effusion, not elsewhere classified
J90 [45605897]
J90 [45605897]
8.8e-01
2.2e+00
3.0e+00
1.0e+50
—
3.0e+00
1.4e+00
cases:0.99%
controls:0.41%
cases:1.97%
controls:0.21%
cases:1.64%
controls:0.08%
cases:0.99%
controls:0.00%
—
—
cases:2.33%
controls:0.12%
cases:2.37%
controls:0.59%
6
25
602
6065
12
13
596
6077
10
5
598
6085
6
0
602
6090
—
12
7
504
5818
9
27
371
4553
Outpatient Visit
OP [9202]
OP [9202]
4.0e-01
5.2e-01
1.1e+00
4.3e+00
1.3e+00
9.6e-01
4.3e-01
cases:85.86%
controls:80.28%
cases:71.38%
controls:59.75%
cases:28.95%
controls:11.74%
cases:27.96%
controls:0.54%
cases:33.22%
controls:11.59%
cases:78.10%
controls:57.80%
cases:89.74%
controls:85.07%
522
4889
86
1201
434
3639
174
2451
176
715
432
5375
170
33
438
6057
198
703
398
5362
403
3367
113
2458
341
3896
39
684
Outpatient Hospital
22 [8756]
22 [8756]
3.9e-01
1.1e+00
2.2e+00
—
2.4e+00
1.3e+00
7.1e-01
cases:35.86%
controls:27.39%
cases:19.41%
controls:7.11%
cases:7.07%
controls:0.80%
—
—
cases:9.23%
controls:0.94%
cases:18.41%
controls:5.96%
cases:28.42%
controls:16.27%
218
1668
390
4422
118
433
490
5657
43
49
565
6041
—
55
57
541
6008
95
347
421
5478
108
745
272
3835
Inpatient Visit
IP [9201]
IP [9201]
6.2e-01
1.2e+00
2.2e+00
1.0e+50
2.7e+00
1.3e+00
4.2e-01
cases:11.68%
controls:6.65%
cases:11.18%
controls:3.60%
cases:3.78%
controls:0.43%
cases:3.95%
controls:0.00%
cases:6.71%
controls:0.46%
cases:12.60%
controls:3.88%
cases:18.16%
controls:12.71%
71
405
537
5685
68
219
540
5871
23
26
585
6064
24
0
584
6090
40
28
556
6037
65
226
451
5599
69
582
311
3998
Protein [Mass/time] in 24 hour Urine
2889-4 [3020876]
2889-4 [3020876]
1.5e+00
2.2e+00
1.0e+50
—
1.0e+50
2.6e+00
1.7e+00
cases:1.48%
controls:0.33%
cases:1.64%
controls:0.18%
cases:0.82%
controls:0.00%
—
—
cases:1.51%
controls:0.00%
cases:2.52%
controls:0.19%
cases:2.37%
controls:0.44%
9
20
599
6070
10
11
598
6079
5
0
603
6090
—
9
0
587
6065
13
11
503
5814
9
20
371
4560
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
4.1e-01
1.3e+00
2.2e+00
—
2.3e+00
1.3e+00
8.2e-01
cases:12.83%
controls:8.88%
cases:14.31%
controls:4.33%
cases:5.43%
controls:0.61%
—
—
cases:6.04%
controls:0.66%
cases:12.60%
controls:3.73%
cases:21.84%
controls:10.94%
78
541
530
5549
87
264
521
5826
33
37
575
6053
—
36
40
560
6025
65
217
451
5608
83
501
297
4079
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
1.4e+00
2.2e+00
—
—
—
2.3e+00
2.0e+00
cases:2.47%
controls:0.59%
cases:2.47%
controls:0.28%
—
—
—
—
—
—
cases:2.13%
controls:0.22%
cases:3.16%
controls:0.46%
15
36
593
6054
15
17
593
6073
—
—
—
11
13
505
5812
12
21
368
4559
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
1.4e+00
2.2e+00
—
—
—
2.3e+00
2.0e+00
cases:2.47%
controls:0.59%
cases:2.47%
controls:0.28%
—
—
—
—
—
—
cases:2.13%
controls:0.22%
cases:3.16%
controls:0.46%
15
36
593
6054
15
17
593
6073
—
—
—
11
13
505
5812
12
21
368
4559
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
5.7e-01
1.1e+00
1.8e+00
—
1.9e+00
1.5e+00
9.6e-01
cases:9.21%
controls:5.40%
cases:4.44%
controls:1.58%
cases:1.32%
controls:0.21%
—
—
cases:1.34%
controls:0.20%
cases:5.23%
controls:1.20%
cases:7.11%
controls:2.84%
56
329
552
5761
27
96
581
5994
8
13
600
6077
—
8
12
588
6053
27
70
489
5755
27
130
353
4450
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
3.4e-01
1.3e+00
2.4e+00
—
2.9e+00
1.2e+00
2.9e-01
cases:5.76%
controls:4.15%
cases:10.03%
controls:2.86%
cases:3.62%
controls:0.33%
—
—
cases:5.03%
controls:0.30%
cases:10.47%
controls:3.38%
cases:16.05%
controls:12.53%
35
253
573
5837
61
174
547
5916
22
20
586
6070
—
30
18
566
6047
54
197
462
5628
61
574
319
4006
potassium chloride; oral
A12BA01 [21600877]
A12BA01 [21600877]
7.1e-01
1.0e+00
1.7e+00
—
1.8e+00
1.7e+00
8.5e-01
cases:4.77%
controls:2.41%
cases:4.61%
controls:1.72%
cases:2.63%
controls:0.48%
—
—
cases:2.85%
controls:0.46%
cases:8.72%
controls:1.72%
cases:10.00%
controls:4.52%
29
147
579
5943
28
105
580
5985
16
29
592
6061
—
17
28
579
6037
45
100
471
5725
38
207
342
4373
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
30934-4 [3011960]
1.2e-01
9.4e-01
2.5e+00
1.0e+50
2.9e+00
1.5e+00
5.1e-01
cases:2.80%
controls:2.50%
cases:2.96%
controls:1.18%
cases:1.15%
controls:0.10%
cases:0.82%
controls:0.00%
cases:1.51%
controls:0.08%
cases:3.88%
controls:0.89%
cases:3.42%
controls:2.07%
17
152
591
5938
18
72
590
6018
7
6
601
6084
5
0
603
6090
9
5
587
6060
20
52
496
5773
13
95
367
4485
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
4.7e-01
1.0e+00
2.3e+00
—
2.4e+00
9.1e-01
6.2e-01
cases:12.83%
controls:8.46%
cases:11.18%
controls:4.29%
cases:4.11%
controls:0.41%
—
—
cases:4.87%
controls:0.45%
cases:9.11%
controls:3.86%
cases:17.63%
controls:10.31%
78
515
530
5575
68
261
540
5829
25
25
583
6065
—
29
27
567
6038
47
225
469
5600
67
472
313
4108
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
5.5e-01
1.6e+00
2.6e+00
—
2.5e+00
1.1e+00
4.4e-01
cases:3.78%
controls:2.22%
cases:4.11%
controls:0.85%
cases:1.48%
controls:0.11%
—
—
cases:1.01%
controls:0.08%
cases:2.91%
controls:0.96%
cases:6.05%
controls:3.97%
23
135
585
5955
25
52
583
6038
9
7
599
6083
—
6
5
590
6060
15
56
501
5769
23
182
357
4398
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
1.4e+00
2.2e+00
—
—
—
2.2e+00
2.0e+00
cases:2.47%
controls:0.59%
cases:2.47%
controls:0.28%
—
—
—
—
—
—
cases:2.13%
controls:0.24%
cases:3.16%
controls:0.46%
15
36
593
6054
15
17
593
6073
—
—
—
11
14
505
5811
12
21
368
4559
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.5e-01
1.3e+00
2.4e+00
—
2.1e+00
1.1e+00
5.5e-01
cases:23.36%
controls:17.72%
cases:24.84%
controls:8.39%
cases:11.68%
controls:1.13%
—
—
cases:9.06%
controls:1.20%
cases:20.74%
controls:8.22%
cases:35.79%
controls:24.34%
142
1079
466
5011
151
511
457
5579
71
69
537
6021
—
54
73
542
5992
107
479
409
5346
136
1115
244
3465
pH of Blood
11558-4 [3010421]
11558-4 [3010421]
1.4e+00
2.3e+00
—
—
—
2.4e+00
1.7e+00
cases:2.63%
controls:0.64%
cases:2.80%
controls:0.30%
—
—
—
—
—
—
cases:3.10%
controls:0.29%
cases:4.47%
controls:0.87%
16
39
592
6051
17
18
591
6072
—
—
—
16
17
500
5808
17
40
363
4540
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
4.6e-01
1.9e+00
2.5e+00
—
—
2.2e+00
1.1e+00
cases:3.78%
controls:2.43%
cases:4.77%
controls:0.76%
cases:1.64%
controls:0.13%
—
—
—
—
cases:5.81%
controls:0.67%
cases:7.11%
controls:2.45%
23
148
585
5942
29
46
579
6044
10
8
598
6082
—
—
30
39
486
5786
27
112
353
4468
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
543-9 [3005702]
1.3e+00
2.6e+00
—
—
—
2.0e+00
1.8e+00
cases:1.97%
controls:0.53%
cases:1.97%
controls:0.15%
—
—
—
—
—
—
cases:1.16%
controls:0.15%
cases:2.37%
controls:0.41%
12
32
596
6058
12
9
596
6081
—
—
—
6
9
510
5816
9
19
371
4561
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
5.0e-01
1.6e+00
2.4e+00
—
2.5e+00
1.1e+00
3.5e-01
cases:3.62%
controls:2.22%
cases:4.28%
controls:0.85%
cases:1.32%
controls:0.11%
—
—
cases:1.01%
controls:0.08%
cases:2.91%
controls:0.96%
cases:5.53%
controls:3.95%
22
135
586
5955
26
52
582
6038
8
7
600
6083
—
6
5
590
6060
15
56
501
5769
21
181
359
4399
Fungus identified in Specimen by Culture
580-1 [3000494]
580-1 [3000494]
4.2e-01
1.0e+00
3.0e+00
—
2.6e+00
1.1e+00
6.7e-01
cases:4.61%
controls:3.09%
cases:2.47%
controls:0.90%
cases:1.64%
controls:0.08%
—
—
cases:1.51%
controls:0.12%
cases:2.91%
controls:0.98%
cases:6.32%
controls:3.32%
28
188
580
5902
15
55
593
6035
10
5
598
6085
—
9
7
587
6058
15
57
501
5768
24
152
356
4428
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
8.6e-01
2.2e+00
—
1.0e+50
2.2e+00
1.6e+00
8.3e-01
cases:6.09%
controls:2.68%
cases:7.57%
controls:0.89%
—
—
cases:1.64%
controls:0.00%
cases:1.51%
controls:0.16%
cases:3.88%
controls:0.82%
cases:6.58%
controls:2.99%
37
163
571
5927
46
54
562
6036
—
10
0
598
6090
9
10
587
6055
20
48
496
5777
25
137
355
4443
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
53027-9 [3041942]
3.2e-01
1.1e+00
3.2e+00
—
3.4e+00
9.8e-01
1.9e-01
cases:4.93%
controls:3.63%
cases:4.11%
controls:1.46%
cases:1.97%
controls:0.08%
—
—
cases:2.52%
controls:0.08%
cases:2.91%
controls:1.12%
cases:5.26%
controls:4.39%
30
221
578
5869
25
89
583
6001
12
5
596
6085
—
15
5
581
6060
15
65
501
5760
20
201
360
4379
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
8.7e-01
1.2e+00
1.8e+00
—
3.0e+00
8.8e-01
4.2e-02
cases:5.43%
controls:2.35%
cases:5.76%
controls:1.79%
cases:2.80%
controls:0.49%
—
—
cases:4.36%
controls:0.23%
cases:4.26%
controls:1.82%
cases:3.68%
controls:3.54%
33
143
575
5947
35
109
573
5981
17
30
591
6060
—
26
14
570
6051
22
106
494
5719
14
162
366
4418
Multiple myeloma
C90.0 [45600562]
C90.0 [45600562]
—
—
—
—
2.9e+00
2.8e+00
1.9e+00
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.08%
cases:2.52%
controls:0.15%
cases:2.11%
controls:0.31%
—
—
—
—
9
5
587
6060
13
9
503
5816
8
14
372
4566
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
3.4e-01
1.0e+00
1.9e+00
—
2.9e+00
1.1e+00
6.9e-01
cases:9.70%
controls:7.11%
cases:10.36%
controls:4.04%
cases:5.59%
controls:0.84%
—
—
cases:9.06%
controls:0.54%
cases:11.05%
controls:3.88%
cases:16.32%
controls:8.93%
59
433
549
5657
63
246
545
5844
34
51
574
6039
—
54
33
542
6032
57
226
459
5599
62
409
318
4171
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
5.0e-01
1.6e+00
2.4e+00
—
2.5e+00
1.1e+00
4.4e-01
cases:3.62%
controls:2.23%
cases:4.11%
controls:0.84%
cases:1.32%
controls:0.11%
—
—
cases:1.01%
controls:0.08%
cases:2.71%
controls:0.94%
cases:6.05%
controls:4.00%
22
136
586
5954
25
51
583
6039
8
7
600
6083
—
6
5
590
6060
14
55
502
5770
23
183
357
4397
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
3.8e-01
1.1e+00
2.2e+00
—
2.6e+00
1.2e+00
6.6e-01
cases:9.38%
controls:6.63%
cases:9.05%
controls:3.32%
cases:4.61%
controls:0.54%
—
—
cases:6.04%
controls:0.49%
cases:8.72%
controls:2.82%
cases:14.74%
controls:8.23%
57
404
551
5686
55
202
553
5888
28
33
580
6057
—
36
30
560
6035
45
164
471
5661
56
377
324
4203
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
5.0e-01
1.6e+00
2.4e+00
—
2.5e+00
1.1e+00
4.4e-01
cases:3.62%
controls:2.23%
cases:4.11%
controls:0.84%
cases:1.32%
controls:0.11%
—
—
cases:1.01%
controls:0.08%
cases:2.71%
controls:0.96%
cases:6.05%
controls:4.00%
22
136
586
5954
25
51
583
6039
8
7
600
6083
—
6
5
590
6060
14
56
502
5769
23
183
357
4397
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
1.3e+00
1.2e+00
—
1.0e+50
2.0e+00
1.7e+00
1.4e+00
cases:2.96%
controls:0.85%
cases:2.30%
controls:0.67%
—
—
cases:1.15%
controls:0.00%
cases:1.17%
controls:0.16%
cases:3.49%
controls:0.64%
cases:6.32%
controls:1.62%
18
52
590
6038
14
41
594
6049
—
7
0
601
6090
7
10
589
6055
18
37
498
5788
24
74
356
4506
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
3.2e-01
1.2e+00
2.4e+00
—
2.3e+00
1.1e+00
6.0e-01
cases:6.58%
controls:4.86%
cases:7.40%
controls:2.36%
cases:3.29%
controls:0.31%
—
—
cases:2.85%
controls:0.30%
cases:6.01%
controls:2.06%
cases:11.84%
controls:6.83%
40
296
568
5794
45
144
563
5946
20
19
588
6071
—
17
18
579
6047
31
120
485
5705
45
313
335
4267
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
6.5e-01
9.9e-01
1.9e+00
—
2.2e+00
1.3e+00
5.6e-01
cases:19.08%
controls:10.94%
cases:11.51%
controls:4.63%
cases:4.44%
controls:0.72%
—
—
cases:7.21%
controls:0.86%
cases:13.76%
controls:4.15%
cases:19.74%
controls:12.29%
116
666
492
5424
70
282
538
5808
27
44
581
6046
—
43
52
553
6013
71
242
445
5583
75
563
305
4017
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
8.2e-01
1.9e+00
—
1.0e+50
2.9e+00
1.8e+00
9.8e-01
cases:3.13%
controls:1.40%
cases:3.62%
controls:0.56%
—
—
cases:1.32%
controls:0.00%
cases:1.51%
controls:0.08%
cases:2.52%
controls:0.45%
cases:5.00%
controls:1.94%
19
85
589
6005
22
34
586
6056
—
8
0
600
6090
9
5
587
6060
13
26
503
5799
19
89
361
4491
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
9.1e-01
1.6e+00
2.7e+00
—
—
1.4e+00
9.6e-01
cases:5.43%
controls:2.27%
cases:4.77%
controls:1.03%
cases:2.30%
controls:0.16%
—
—
—
—
cases:4.84%
controls:1.24%
cases:8.16%
controls:3.28%
33
138
575
5952
29
63
579
6027
14
10
594
6080
—
—
25
72
491
5753
31
150
349
4430
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
80223-1 [21494815]
1.1e+00
2.6e+00
—
—
—
2.4e+00
2.4e+00
cases:0.82%
controls:0.26%
cases:1.32%
controls:0.10%
—
—
—
—
—
—
cases:1.16%
controls:0.10%
cases:3.42%
controls:0.31%
5
16
603
6074
8
6
600
6084
—
—
—
6
6
510
5819
13
14
367
4566
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
1.7e+00
2.9e+00
—
—
—
2.6e+00
1.9e+00
cases:1.15%
controls:0.21%
cases:1.48%
controls:0.08%
—
—
—
—
—
—
cases:2.13%
controls:0.15%
cases:2.37%
controls:0.35%
7
13
601
6077
9
5
599
6085
—
—
—
11
9
505
5816
9
16
371
4564
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
E87.1 [45542779]
1.6e+00
1.9e+00
—
1.0e+50
—
2.4e+00
1.5e+00
cases:1.97%
controls:0.39%
cases:1.32%
controls:0.20%
—
—
cases:1.64%
controls:0.00%
—
—
cases:0.97%
controls:0.09%
cases:3.16%
controls:0.72%
12
24
596
6066
8
12
600
6078
—
10
0
598
6090
—
5
5
511
5820
12
33
368
4547
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-1.1e-01
1.8e-01
1.5e+00
4.2e+00
1.7e+00
2.1e-01
-3.1e-01
cases:34.87%
controls:37.45%
cases:32.89%
controls:29.11%
cases:24.34%
controls:6.45%
cases:22.86%
controls:0.43%
cases:25.67%
controls:6.02%
cases:34.11%
controls:29.53%
cases:39.74%
controls:47.40%
212
2281
396
3809
200
1773
408
4317
148
393
460
5697
139
26
469
6064
153
365
443
5700
176
1720
340
4105
151
2171
229
2409
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
3.0e-01
1.2e+00
1.9e+00
1.0e+50
3.0e+00
1.3e+00
3.3e-01
cases:2.47%
controls:1.84%
cases:3.45%
controls:1.10%
cases:1.81%
controls:0.26%
cases:0.82%
controls:0.00%
cases:2.35%
controls:0.12%
cases:3.68%
controls:1.03%
cases:3.95%
controls:2.86%
15
112
593
5978
21
67
587
6023
11
16
597
6074
5
0
603
6090
14
7
582
6058
19
60
497
5765
15
131
365
4449
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2704-5 [3028626]
1.7e+00
2.6e+00
—
—
—
1.7e+00
1.4e+00
cases:1.81%
controls:0.33%
cases:2.30%
controls:0.18%
—
—
—
—
—
—
cases:2.13%
controls:0.38%
cases:4.47%
controls:1.14%
11
20
597
6070
14
11
594
6079
—
—
—
11
22
505
5803
17
52
363
4528
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
4.0e-01
1.1e+00
2.6e+00
1.0e+50
2.1e+00
1.1e+00
3.6e-01
cases:16.28%
controls:11.51%
cases:16.45%
controls:6.03%
cases:8.88%
controls:0.69%
cases:6.25%
controls:0.00%
cases:7.38%
controls:0.96%
cases:16.28%
controls:5.85%
cases:21.84%
controls:16.33%
99
701
509
5389
100
367
508
5723
54
42
554
6048
38
0
570
6090
44
58
552
6007
84
341
432
5484
83
748
297
3832
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
1.2e+00
2.4e+00
—
—
—
3.4e+00
1.6e+00
cases:1.32%
controls:0.41%
cases:1.97%
controls:0.18%
—
—
—
—
—
—
cases:3.10%
controls:0.10%
cases:2.37%
controls:0.50%
8
25
600
6065
12
11
596
6079
—
—
—
16
6
500
5819
9
23
371
4557
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
2.0e-01
1.1e+00
2.4e+00
—
2.3e+00
1.0e+00
5.6e-01
cases:24.34%
controls:20.82%
cases:27.63%
controls:10.92%
cases:15.46%
controls:1.59%
—
—
cases:13.42%
controls:1.58%
cases:24.03%
controls:10.39%
cases:38.95%
controls:26.62%
148
1268
460
4822
168
665
440
5425
94
97
514
5993
—
80
96
516
5969
124
605
392
5220
148
1219
232
3361
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
35559-4 [3035797]
3.1e-01
2.5e+00
—
1.0e+50
—
3.1e+00
1.7e+00
cases:0.99%
controls:0.72%
cases:2.80%
controls:0.23%
—
—
cases:0.82%
controls:0.00%
—
—
cases:5.23%
controls:0.24%
cases:5.79%
controls:1.07%
6
44
602
6046
17
14
591
6076
—
5
0
603
6090
—
27
14
489
5811
22
49
358
4531
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
-2.3e-02
1.0e+00
2.7e+00
1.0e+50
2.7e+00
9.7e-01
2.5e-01
cases:4.77%
controls:4.88%
cases:7.07%
controls:2.63%
cases:3.78%
controls:0.26%
cases:3.13%
controls:0.00%
cases:3.19%
controls:0.23%
cases:6.20%
controls:2.44%
cases:9.21%
controls:7.29%
29
297
579
5793
43
160
565
5930
23
16
585
6074
19
0
589
6090
19
14
577
6051
32
142
484
5683
35
334
345
4246
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
4.0e-01
1.2e+00
2.9e+00
1.0e+50
2.1e+00
1.2e+00
4.5e-01
cases:11.18%
controls:7.78%
cases:12.01%
controls:3.83%
cases:6.58%
controls:0.39%
cases:4.44%
controls:0.00%
cases:5.03%
controls:0.66%
cases:11.05%
controls:3.78%
cases:15.26%
controls:10.28%
68
474
540
5616
73
233
535
5857
40
24
568
6066
27
0
581
6090
30
40
566
6025
57
220
459
5605
58
471
322
4109
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
2.7e-01
1.1e+00
2.1e+00
1.0e+50
2.8e+00
1.3e+00
1.2e-01
cases:9.38%
controls:7.29%
cases:6.58%
controls:2.27%
cases:1.48%
controls:0.18%
cases:1.32%
controls:0.00%
cases:3.36%
controls:0.21%
cases:5.04%
controls:1.39%
cases:7.63%
controls:6.83%
57
444
551
5646
40
138
568
5952
9
11
599
6079
8
0
600
6090
20
13
576
6052
26
81
490
5744
29
313
351
4267
Immunofixation for Serum or Plasma
25700-6 [3037756]
25700-6 [3037756]
1.2e+00
2.8e+00
1.0e+50
—
—
2.9e+00
1.5e+00
cases:1.81%
controls:0.54%
cases:3.29%
controls:0.20%
cases:2.30%
controls:0.00%
—
—
—
—
cases:3.68%
controls:0.21%
cases:2.89%
controls:0.63%
11
33
597
6057
20
12
588
6078
14
0
594
6090
—
—
19
12
497
5813
11
29
369
4551
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
3.6e-01
1.2e+00
2.0e+00
—
2.0e+00
1.2e+00
8.5e-01
cases:10.03%
controls:7.19%
cases:6.09%
controls:1.86%
cases:1.32%
controls:0.18%
—
—
cases:1.51%
controls:0.21%
cases:5.23%
controls:1.60%
cases:13.16%
controls:6.07%
61
438
547
5652
37
113
571
5977
8
11
600
6079
—
9
13
587
6052
27
93
489
5732
50
278
330
4302
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
11572-5 [3021614]
4.0e-01
9.1e-01
2.8e+00
—
3.5e+00
9.2e-01
4.5e-02
cases:5.76%
controls:3.92%
cases:3.78%
controls:1.56%
cases:2.47%
controls:0.15%
—
—
cases:3.19%
controls:0.10%
cases:3.10%
controls:1.25%
cases:5.26%
controls:5.04%
35
239
573
5851
23
95
585
5995
15
9
593
6081
—
19
6
577
6059
16
73
500
5752
20
231
360
4349
Extracorporeal dialysis
Z49.1 [45537649]
Z49.1 [45537649]
2.3e+00
—
—
—
2.3e+00
2.6e+00
—
cases:1.48%
controls:0.15%
—
—
—
—
—
—
cases:1.01%
controls:0.10%
cases:1.36%
controls:0.10%
—
—
9
9
599
6081
—
—
—
6
6
590
6059
7
6
509
5819
—
Gas panel - Central venous blood
97535-9 [1616796]
97535-9 [1616796]
1.6e+00
2.2e+00
—
—
—
1.9e+00
1.4e+00
cases:2.30%
controls:0.46%
cases:2.63%
controls:0.30%
—
—
—
—
—
—
cases:2.13%
controls:0.31%
cases:3.16%
controls:0.76%
14
28
594
6062
16
18
592
6072
—
—
—
11
18
505
5807
12
35
368
4545
Bone marrow Pathology biopsy report
33721-2 [3045142]
33721-2 [3045142]
1.1e+00
2.3e+00
—
—
1.0e+50
3.0e+00
1.9e+00
cases:0.82%
controls:0.28%
cases:1.15%
controls:0.11%
—
—
—
—
cases:1.17%
controls:0.00%
cases:1.74%
controls:0.09%
cases:2.11%
controls:0.33%
5
17
603
6073
7
7
601
6083
—
—
7
0
589
6065
9
5
507
5820
8
15
372
4565
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
1.0e+00
1.6e+00
—
1.0e+50
2.7e+00
1.9e+00
7.2e-01
cases:2.96%
controls:1.07%
cases:3.13%
controls:0.66%
—
—
cases:2.47%
controls:0.00%
cases:1.85%
controls:0.13%
cases:3.68%
controls:0.55%
cases:5.53%
controls:2.77%
18
65
590
6025
19
40
589
6050
—
15
0
593
6090
11
8
585
6057
19
32
497
5793
21
127
359
4453
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
7.5e-01
1.1e+00
7.6e-01
6.9e-01
7.0e-01
1.6e+00
2.4e+00
cases:98.52%
controls:96.93%
cases:96.55%
controls:90.41%
cases:73.36%
controls:56.21%
cases:5.59%
controls:2.87%
cases:71.48%
controls:55.56%
cases:97.87%
controls:90.47%
cases:99.74%
controls:97.21%
599
5903
9
187
587
5506
21
584
446
3423
162
2667
34
175
574
5915
426
3370
170
2695
505
5270
11
555
379
4452
1
128
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
4.2e-01
1.0e+00
1.2e+00
—
2.0e+00
1.6e+00
9.2e-01
cases:18.09%
controls:12.63%
cases:13.65%
controls:5.37%
cases:4.11%
controls:1.25%
—
—
cases:7.72%
controls:1.15%
cases:23.06%
controls:5.46%
cases:27.89%
controls:13.41%
110
769
498
5321
83
327
525
5763
25
76
583
6014
—
46
70
550
5995
119
318
397
5507
106
614
274
3966
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
4.3e-01
1.0e+00
1.2e+00
—
2.0e+00
1.6e+00
9.1e-01
cases:18.26%
controls:12.69%
cases:13.65%
controls:5.37%
cases:4.11%
controls:1.25%
—
—
cases:7.72%
controls:1.15%
cases:23.06%
controls:5.49%
cases:27.89%
controls:13.52%
111
773
497
5317
83
327
525
5763
25
76
583
6014
—
46
70
550
5995
119
320
397
5505
106
619
274
3961
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
5.0e-01
2.5e+00
—
1.0e+50
—
3.1e+00
1.6e+00
cases:1.32%
controls:0.80%
cases:3.45%
controls:0.30%
—
—
cases:0.99%
controls:0.00%
—
—
cases:6.20%
controls:0.31%
cases:6.58%
controls:1.35%
8
49
600
6041
21
18
587
6072
—
6
0
602
6090
—
32
18
484
5807
25
62
355
4518
Neutrophils [#/volume] in Blood
26499-4 [3017732]
26499-4 [3017732]
-1.4e-01
1.0e+00
2.2e+00
1.0e+50
2.9e+00
1.1e+00
1.9e-01
cases:1.32%
controls:1.51%
cases:2.96%
controls:1.08%
cases:1.81%
controls:0.21%
cases:0.99%
controls:0.00%
cases:2.68%
controls:0.15%
cases:3.68%
controls:1.30%
cases:5.53%
controls:4.61%
8
92
600
5998
18
66
590
6024
11
13
597
6077
6
0
602
6090
16
9
580
6056
19
76
497
5749
21
211
359
4369
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
3.6e-01
1.1e+00
2.6e+00
—
2.4e+00
1.1e+00
3.8e-01
cases:18.75%
controls:13.84%
cases:21.55%
controls:8.23%
cases:11.68%
controls:1.00%
—
—
cases:10.40%
controls:1.09%
cases:21.90%
controls:8.48%
cases:30.26%
controls:22.86%
114
843
494
5247
131
501
477
5589
71
61
537
6029
—
62
66
534
5999
113
494
403
5331
115
1047
265
3533
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
50796-2 [3029338]
2.3e-01
2.3e+00
—
—
—
3.1e+00
1.7e+00
cases:0.82%
controls:0.66%
cases:2.14%
controls:0.21%
—
—
—
—
—
—
cases:4.84%
controls:0.22%
cases:5.26%
controls:1.00%
5
40
603
6050
13
13
595
6077
—
—
—
25
13
491
5812
20
46
360
4534
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
3.0e-01
1.1e+00
2.6e+00
—
2.4e+00
1.1e+00
3.2e-01
cases:17.60%
controls:13.63%
cases:20.72%
controls:8.11%
cases:11.68%
controls:0.99%
—
—
cases:10.57%
controls:1.07%
cases:21.32%
controls:8.45%
cases:28.95%
controls:22.77%
107
830
501
5260
126
494
482
5596
71
60
537
6030
—
63
65
533
6000
110
492
406
5333
110
1043
270
3537
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
8.5e-01
1.7e+00
2.9e+00
1.0e+50
—
1.6e+00
3.8e-01
cases:3.62%
controls:1.58%
cases:4.44%
controls:0.82%
cases:2.14%
controls:0.11%
cases:2.47%
controls:0.00%
—
—
cases:3.68%
controls:0.76%
cases:5.53%
controls:3.84%
22
96
586
5994
27
50
581
6040
13
7
595
6083
15
0
593
6090
—
19
44
497
5781
21
176
359
4404
Rheumatology
66 [38004491]
66 [38004491]
5.5e-01
7.3e-01
1.3e+00
—
2.0e+00
1.7e+00
1.4e+00
cases:6.91%
controls:4.11%
cases:4.93%
controls:2.45%
cases:1.97%
controls:0.54%
—
—
cases:3.36%
controls:0.48%
cases:11.63%
controls:2.28%
cases:13.16%
controls:3.69%
42
250
566
5840
30
149
578
5941
12
33
596
6057
—
20
29
576
6036
60
133
456
5692
50
169
330
4411
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
4.2e-01
1.3e+00
1.8e+00
—
1.9e+00
1.5e+00
6.3e-01
cases:10.03%
controls:6.80%
cases:7.24%
controls:2.09%
cases:1.97%
controls:0.33%
—
—
cases:2.18%
controls:0.33%
cases:7.56%
controls:1.85%
cases:10.53%
controls:5.87%
61
414
547
5676
44
127
564
5963
12
20
596
6070
—
13
20
583
6045
39
108
477
5717
40
269
340
4311
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
3.3e-01
1.1e+00
2.6e+00
—
2.4e+00
1.1e+00
3.4e-01
cases:17.60%
controls:13.27%
cases:20.39%
controls:8.00%
cases:11.51%
controls:0.99%
—
—
cases:10.40%
controls:1.09%
cases:21.12%
controls:8.41%
cases:28.95%
controls:22.47%
107
808
501
5282
124
487
484
5603
70
60
538
6030
—
62
66
534
5999
109
490
407
5335
110
1029
270
3551
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
50797-0 [3029379]
2.5e-01
2.3e+00
—
—
—
3.2e+00
1.6e+00
cases:0.82%
controls:0.64%
cases:2.14%
controls:0.21%
—
—
—
—
—
—
cases:4.46%
controls:0.19%
cases:4.47%
controls:0.98%
5
39
603
6051
13
13
595
6077
—
—
—
23
11
493
5814
17
45
363
4535
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
51628-6 [3042111]
1.2e+00
2.6e+00
—
1.0e+50
—
3.0e+00
1.5e+00
cases:0.99%
controls:0.30%
cases:1.48%
controls:0.11%
—
—
cases:0.82%
controls:0.00%
—
—
cases:2.33%
controls:0.12%
cases:2.37%
controls:0.55%
6
18
602
6072
9
7
599
6083
—
5
0
603
6090
—
12
7
504
5818
9
25
371
4555
Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]
14866-8 [3010566]
1.5e+00
1.9e+00
—
—
—
2.0e+00
1.5e+00
cases:1.97%
controls:0.46%
cases:1.97%
controls:0.30%
—
—
—
—
—
—
cases:1.94%
controls:0.26%
cases:2.37%
controls:0.52%
12
28
596
6062
12
18
596
6072
—
—
—
10
15
506
5810
9
24
371
4556
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
3.0e-01
1.2e+00
2.6e+00
—
2.2e+00
8.7e-01
4.6e-01
cases:4.28%
controls:3.20%
cases:6.74%
controls:2.04%
cases:3.13%
controls:0.23%
—
—
cases:3.02%
controls:0.35%
cases:5.23%
controls:2.27%
cases:9.74%
controls:6.38%
26
195
582
5895
41
124
567
5966
19
14
589
6076
—
18
21
578
6044
27
132
489
5693
37
292
343
4288
General Surgery
2 [38004447]
2 [38004447]
3.6e-01
8.6e-01
1.7e+00
—
2.3e+00
1.1e+00
6.0e-01
cases:22.70%
controls:16.96%
cases:10.69%
controls:4.81%
cases:3.29%
controls:0.62%
—
—
cases:5.87%
controls:0.63%
cases:12.60%
controls:4.53%
cases:20.79%
controls:12.58%
138
1033
470
5057
65
293
543
5797
20
38
588
6052
—
35
38
561
6027
65
264
451
5561
79
576
301
4004
Cells panel - Urine sediment
58434-2 [40761535]
58434-2 [40761535]
7.2e-01
1.1e+00
2.3e+00
1.0e+50
2.7e+00
9.3e-01
2.2e-01
cases:5.10%
controls:2.55%
cases:3.62%
controls:1.22%
cases:1.64%
controls:0.16%
cases:1.48%
controls:0.00%
cases:1.51%
controls:0.10%
cases:2.33%
controls:0.93%
cases:3.42%
controls:2.77%
31
155
577
5935
22
74
586
6016
10
10
598
6080
9
0
599
6090
9
6
587
6059
12
54
504
5771
13
127
367
4453
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
2.0e+00
2.4e+00
—
—
—
2.4e+00
—
cases:1.81%
controls:0.25%
cases:1.64%
controls:0.15%
—
—
—
—
—
—
cases:1.55%
controls:0.14%
—
—
11
15
597
6075
10
9
598
6081
—
—
—
8
8
508
5817
—
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
4.6e-01
1.1e+00
1.8e+00
—
2.1e+00
1.0e+00
7.3e-01
cases:9.38%
controls:6.11%
cases:6.09%
controls:2.02%
cases:1.48%
controls:0.25%
—
—
cases:2.18%
controls:0.26%
cases:5.04%
controls:1.89%
cases:11.32%
controls:5.81%
57
372
551
5718
37
123
571
5967
9
15
599
6075
—
13
16
583
6049
26
110
490
5715
43
266
337
4314
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
9.8e-01
1.2e+00
1.3e+00
—
1.5e+00
1.1e+00
7.4e-01
cases:19.08%
controls:8.14%
cases:19.24%
controls:7.00%
cases:8.88%
controls:2.59%
—
—
cases:8.56%
controls:2.03%
cases:20.16%
controls:7.50%
cases:23.68%
controls:12.93%
116
496
492
5594
117
426
491
5664
54
158
554
5932
—
51
123
545
5942
104
437
412
5388
90
592
290
3988
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
3.1e-01
1.3e+00
2.0e+00
1.0e+50
2.3e+00
1.2e+00
3.2e-01
cases:10.69%
controls:8.10%
cases:12.34%
controls:3.74%
cases:3.29%
controls:0.44%
cases:1.81%
controls:0.00%
cases:4.70%
controls:0.51%
cases:9.69%
controls:3.14%
cases:13.16%
controls:9.89%
65
493
543
5597
75
228
533
5862
20
27
588
6063
11
0
597
6090
28
31
568
6034
50
183
466
5642
50
453
330
4127
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
SPAT1230 [2001700331]
5.5e-01
1.1e+00
2.5e+00
—
2.2e+00
9.4e-01
9.7e-01
cases:5.59%
controls:3.32%
cases:3.29%
controls:1.13%
cases:0.99%
controls:0.08%
—
—
cases:1.34%
controls:0.15%
cases:2.71%
controls:1.08%
cases:8.42%
controls:3.36%
34
202
574
5888
20
69
588
6021
6
5
602
6085
—
8
9
588
6056
14
63
502
5762
32
154
348
4426
Pulmonary Disease
29 [38004472]
29 [38004472]
5.6e-01
9.4e-01
1.3e+00
—
1.9e+00
1.3e+00
8.3e-01
cases:16.94%
controls:10.48%
cases:12.99%
controls:5.53%
cases:4.28%
controls:1.20%
—
—
cases:5.54%
controls:0.89%
cases:16.09%
controls:5.17%
cases:21.84%
controls:10.90%
103
638
505
5452
79
337
529
5753
26
73
582
6017
—
33
54
563
6011
83
301
433
5524
83
499
297
4081
Erysipelas
A46 [45561706]
A46 [45561706]
9.4e-01
1.5e+00
2.3e+00
1.0e+50
—
1.2e+00
8.4e-01
cases:5.76%
controls:2.33%
cases:3.29%
controls:0.79%
cases:0.99%
controls:0.10%
cases:1.64%
controls:0.00%
—
—
cases:2.71%
controls:0.82%
cases:6.32%
controls:2.84%
35
142
573
5948
20
48
588
6042
6
6
602
6084
10
0
598
6090
—
14
48
502
5777
24
130
356
4450
Emergency Medicine
93 [38004510]
93 [38004510]
4.5e-01
1.1e+00
2.5e+00
—
1.6e+00
7.2e-01
3.7e-01
cases:26.81%
controls:18.90%
cases:25.33%
controls:10.18%
cases:14.80%
controls:1.44%
—
—
cases:7.55%
controls:1.58%
cases:19.77%
controls:10.68%
cases:37.37%
controls:29.08%
163
1151
445
4939
154
620
454
5470
90
88
518
6002
—
45
96
551
5969
102
622
414
5203
142
1332
238
3248
Acute tubulo-interstitial nephritis
N10 [45543856]
N10 [45543856]
6.7e-01
1.5e+00
2.7e+00
—
—
1.6e+00
9.2e-01
cases:3.45%
controls:1.81%
cases:3.29%
controls:0.72%
cases:1.15%
controls:0.08%
—
—
—
—
cases:2.71%
controls:0.55%
cases:5.79%
controls:2.40%
21
110
587
5980
20
44
588
6046
7
5
601
6085
—
—
14
32
502
5793
22
110
358
4470
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
4.4e-01
2.2e+00
—
1.0e+50
—
2.9e+00
1.6e+00
cases:1.32%
controls:0.85%
cases:2.96%
controls:0.33%
—
—
cases:0.82%
controls:0.00%
—
—
cases:5.43%
controls:0.31%
cases:6.58%
controls:1.44%
8
52
600
6038
18
20
590
6070
—
5
0
603
6090
—
28
18
488
5807
25
66
355
4514
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
4.4e-01
2.2e+00
—
1.0e+50
—
2.9e+00
1.6e+00
cases:1.32%
controls:0.85%
cases:2.96%
controls:0.33%
—
—
cases:0.82%
controls:0.00%
—
—
cases:5.43%
controls:0.31%
cases:6.58%
controls:1.44%
8
52
600
6038
18
20
590
6070
—
5
0
603
6090
—
28
18
488
5807
25
66
355
4514
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
4.4e-01
2.2e+00
—
1.0e+50
—
2.9e+00
1.6e+00
cases:1.32%
controls:0.85%
cases:2.96%
controls:0.33%
—
—
cases:0.82%
controls:0.00%
—
—
cases:5.43%
controls:0.31%
cases:6.58%
controls:1.44%
8
52
600
6038
18
20
590
6070
—
5
0
603
6090
—
28
18
488
5807
25
66
355
4514
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
—
2.6e+00
—
—
—
2.5e+00
1.6e+00
—
—
cases:2.14%
controls:0.16%
—
—
—
—
—
—
cases:2.33%
controls:0.19%
cases:4.21%
controls:0.90%
—
13
10
595
6080
—
—
—
12
11
504
5814
16
41
364
4539
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
5.2e-01
2.2e+00
—
1.0e+50
—
3.0e+00
1.4e+00
cases:1.32%
controls:0.79%
cases:2.96%
controls:0.34%
—
—
cases:0.82%
controls:0.00%
—
—
cases:5.43%
controls:0.27%
cases:5.53%
controls:1.35%
8
48
600
6042
18
21
590
6069
—
5
0
603
6090
—
28
16
488
5809
21
62
359
4518
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
3.0e-01
1.2e+00
1.9e+00
—
2.5e+00
1.1e+00
2.9e-01
cases:14.97%
controls:11.54%
cases:15.79%
controls:5.35%
cases:3.62%
controls:0.54%
—
—
cases:6.21%
controls:0.56%
cases:11.43%
controls:4.24%
cases:18.95%
controls:14.87%
91
703
517
5387
96
326
512
5764
22
33
586
6057
—
37
34
559
6031
59
247
457
5578
72
681
308
3899
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
2.5e-01
1.1e+00
2.4e+00
—
2.1e+00
1.0e+00
4.7e-01
cases:9.38%
controls:7.44%
cases:11.18%
controls:4.11%
cases:6.25%
controls:0.61%
—
—
cases:5.37%
controls:0.66%
cases:11.05%
controls:4.21%
cases:18.16%
controls:12.18%
57
453
551
5637
68
250
540
5840
38
37
570
6053
—
32
40
564
6025
57
245
459
5580
69
558
311
4022
Protein [Mass/volume] in Pleural fluid
2882-9 [3003434]
2882-9 [3003434]
2.2e+00
2.7e+00
1.0e+50
—
1.0e+50
—
1.8e+00
cases:0.99%
controls:0.11%
cases:1.97%
controls:0.13%
cases:0.99%
controls:0.00%
—
—
cases:1.51%
controls:0.00%
—
—
cases:2.11%
controls:0.37%
6
7
602
6083
12
8
596
6082
6
0
602
6090
—
9
0
587
6065
—
8
17
372
4563
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
3.2e-01
2.0e+00
—
—
—
3.0e+00
1.6e+00
cases:1.15%
controls:0.84%
cases:1.97%
controls:0.28%
—
—
—
—
—
—
cases:4.46%
controls:0.22%
cases:5.79%
controls:1.20%
7
51
601
6039
12
17
596
6073
—
—
—
23
13
493
5812
22
55
358
4525
Polymyalgia rheumatica
M35.3 [45533830]
M35.3 [45533830]
1.8e-01
8.4e-01
—
1.0e+50
2.6e+00
2.3e+00
1.7e+00
cases:0.82%
controls:0.69%
cases:0.99%
controls:0.43%
—
—
cases:1.15%
controls:0.00%
cases:1.34%
controls:0.10%
cases:2.91%
controls:0.31%
cases:4.74%
controls:0.90%
5
42
603
6048
6
26
602
6064
—
7
0
601
6090
8
6
588
6059
15
18
501
5807
18
41
362
4539
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
14278-6 [3003284]
—
2.2e+00
1.0e+50
—
—
2.6e+00
1.7e+00
—
—
cases:1.32%
controls:0.15%
cases:0.82%
controls:0.00%
—
—
—
—
cases:1.16%
controls:0.09%
cases:3.42%
controls:0.61%
—
8
9
600
6081
5
0
603
6090
—
—
6
5
510
5820
13
28
367
4552
Bacteria identified in Sputum by Culture
6460-0 [3023419]
6460-0 [3023419]
1.7e+00
2.3e+00
—
—
—
2.6e+00
—
cases:1.48%
controls:0.28%
cases:0.99%
controls:0.10%
—
—
—
—
—
—
cases:1.55%
controls:0.12%
—
—
9
17
599
6073
6
6
602
6084
—
—
—
8
7
508
5818
—
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
2.1e-01
9.7e-01
1.8e+00
1.0e+50
2.3e+00
8.7e-01
5.3e-01
cases:23.03%
controls:19.56%
cases:21.22%
controls:9.24%
cases:7.24%
controls:1.22%
cases:4.28%
controls:0.00%
cases:10.23%
controls:1.09%
cases:18.60%
controls:8.77%
cases:33.16%
controls:22.53%
140
1191
468
4899
129
563
479
5527
44
74
564
6016
26
0
582
6090
61
66
535
5999
96
511
420
5314
126
1032
254
3548
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
31017-7 [3019050]
3.2e-01
1.2e+00
2.5e+00
—
2.8e+00
8.3e-01
7.2e-02
cases:6.91%
controls:5.12%
cases:5.92%
controls:1.86%
cases:2.14%
controls:0.18%
—
—
cases:3.02%
controls:0.18%
cases:3.49%
controls:1.55%
cases:6.05%
controls:5.66%
42
312
566
5778
36
113
572
5977
13
11
595
6079
—
18
11
578
6054
18
90
498
5735
23
259
357
4321
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
1.5e-01
8.0e-01
2.3e+00
—
2.4e+00
9.4e-01
1.1e-01
cases:6.58%
controls:5.71%
cases:8.06%
controls:3.79%
cases:4.77%
controls:0.48%
—
—
cases:4.36%
controls:0.40%
cases:9.69%
controls:4.02%
cases:12.11%
controls:11.03%
40
348
568
5742
49
231
559
5859
29
29
579
6061
—
26
24
570
6041
50
234
466
5591
46
505
334
4075
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
3.5e-01
1.1e+00
1.8e+00
1.0e+50
2.3e+00
1.2e+00
5.0e-01
cases:7.89%
controls:5.71%
cases:8.06%
controls:2.86%
cases:2.30%
controls:0.38%
cases:0.99%
controls:0.00%
cases:3.02%
controls:0.30%
cases:7.56%
controls:2.33%
cases:11.32%
controls:7.21%
48
348
560
5742
49
174
559
5916
14
23
594
6067
6
0
602
6090
18
18
578
6047
39
136
477
5689
43
330
337
4250
Protein [Mass/volume] in Urine
2888-6 [3037121]
2888-6 [3037121]
7.2e-01
2.0e+00
2.9e+00
—
—
1.6e+00
8.7e-01
cases:2.14%
controls:1.05%
cases:2.96%
controls:0.41%
cases:1.48%
controls:0.08%
—
—
—
—
cases:2.13%
controls:0.45%
cases:2.37%
controls:1.00%
13
64
595
6026
18
25
590
6065
9
5
599
6085
—
—
11
26
505
5799
9
46
371
4534
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
6.7e-01
9.6e-01
1.3e+00
1.1e+00
1.6e+00
8.8e-01
3.9e-01
cases:12.99%
controls:7.08%
cases:11.51%
controls:4.75%
cases:5.59%
controls:1.64%
cases:2.14%
controls:0.74%
cases:7.89%
controls:1.67%
cases:11.24%
controls:5.00%
cases:18.95%
controls:13.71%
79
431
529
5659
70
289
538
5801
34
100
574
5990
13
45
595
6045
47
101
549
5964
58
291
458
5534
72
628
308
3952
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
1.1e-01
1.1e+00
2.6e+00
—
2.1e+00
7.3e-01
3.5e-01
cases:3.62%
controls:3.27%
cases:5.92%
controls:2.15%
cases:2.96%
controls:0.23%
—
—
cases:2.85%
controls:0.36%
cases:5.23%
controls:2.59%
cases:10.00%
controls:7.27%
22
199
586
5891
36
131
572
5959
18
14
590
6076
—
17
22
579
6043
27
151
489
5674
38
333
342
4247
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
3.8e-01
9.7e-01
1.7e+00
—
2.2e+00
9.7e-01
5.6e-01
cases:15.30%
controls:10.99%
cases:15.13%
controls:6.31%
cases:4.11%
controls:0.76%
—
—
cases:6.38%
controls:0.76%
cases:14.92%
controls:6.21%
cases:27.63%
controls:17.95%
93
669
515
5421
92
384
516
5706
25
46
583
6044
—
38
46
558
6019
77
362
439
5463
105
822
275
3758
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
7.1e-01
1.4e+00
—
1.0e+50
2.6e+00
1.7e+00
5.3e-01
cases:10.20%
controls:5.27%
cases:6.74%
controls:1.79%
—
—
cases:1.64%
controls:0.00%
cases:2.85%
controls:0.21%
cases:7.75%
controls:1.49%
cases:8.68%
controls:5.31%
62
321
546
5769
41
109
567
5981
—
10
0
598
6090
17
13
579
6052
40
87
476
5738
33
243
347
4337
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
5.3e-01
7.3e-01
2.2e+00
1.0e+50
2.0e+00
9.5e-01
1.9e-01
cases:11.02%
controls:6.80%
cases:6.91%
controls:3.45%
cases:3.13%
controls:0.36%
cases:3.78%
controls:0.00%
cases:4.70%
controls:0.66%
cases:8.33%
controls:3.38%
cases:11.84%
controls:10.02%
67
414
541
5676
42
210
566
5880
19
22
589
6068
23
0
585
6090
28
40
568
6025
43
197
473
5628
45
459
335
4121
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
A04AA01 [21600493]
1.4e+00
1.5e+00
—
—
—
2.2e+00
1.3e+00
cases:2.47%
controls:0.64%
cases:1.64%
controls:0.36%
—
—
—
—
—
—
cases:3.10%
controls:0.36%
cases:3.95%
controls:1.09%
15
39
593
6051
10
22
598
6068
—
—
—
16
21
500
5804
15
50
365
4530
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
14277-8 [3004383]
—
2.2e+00
1.0e+50
—
—
2.4e+00
1.7e+00
—
—
cases:1.32%
controls:0.15%
cases:0.82%
controls:0.00%
—
—
—
—
cases:1.16%
controls:0.10%
cases:3.42%
controls:0.61%
—
8
9
600
6081
5
0
603
6090
—
—
6
6
510
5819
13
28
367
4552
Bone marrow biopsy
XW000 [2001310618]
XW000 [2001310618]
9.9e-01
2.5e+00
—
1.0e+50
1.0e+50
2.4e+00
1.4e+00
cases:1.32%
controls:0.49%
cases:2.30%
controls:0.20%
—
—
cases:1.97%
controls:0.00%
cases:1.51%
controls:0.00%
cases:2.13%
controls:0.19%
cases:2.63%
controls:0.63%
8
30
600
6060
14
12
594
6078
—
12
0
596
6090
9
0
587
6065
11
11
505
5814
10
29
370
4551
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2469-5 [3024980]
—
2.5e+00
—
—
—
2.1e+00
1.7e+00
—
—
cases:0.99%
controls:0.08%
—
—
—
—
—
—
cases:1.36%
controls:0.17%
cases:1.84%
controls:0.33%
—
6
5
602
6085
—
—
—
7
10
509
5815
7
15
373
4565
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
6.9e-01
1.2e+00
1.2e+00
—
1.4e+00
1.1e+00
8.3e-01
cases:15.30%
controls:8.34%
cases:9.05%
controls:3.04%
cases:2.30%
controls:0.72%
—
—
cases:2.01%
controls:0.53%
cases:8.72%
controls:3.06%
cases:15.53%
controls:7.42%
93
508
515
5582
55
185
553
5905
14
44
594
6046
—
12
32
584
6033
45
178
471
5647
59
340
321
4240
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
2.7e-01
1.2e+00
2.6e+00
—
2.3e+00
1.4e+00
8.9e-01
cases:1.97%
controls:1.51%
cases:1.81%
controls:0.54%
cases:1.32%
controls:0.10%
—
—
cases:0.84%
controls:0.08%
cases:1.94%
controls:0.50%
cases:3.68%
controls:1.55%
12
92
596
5998
11
33
597
6057
8
6
600
6084
—
5
5
591
6060
10
29
506
5796
14
71
366
4509
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
88518-6 [36304997]
3.9e-01
2.2e+00
—
—
—
2.4e+00
1.7e+00
cases:0.99%
controls:0.67%
cases:0.99%
controls:0.11%
—
—
—
—
—
—
cases:2.13%
controls:0.19%
cases:4.21%
controls:0.81%
6
41
602
6049
6
7
602
6083
—
—
—
11
11
505
5814
16
37
364
4543
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
2.0e-01
1.0e+00
1.9e+00
1.0e+50
2.4e+00
9.1e-01
2.4e-01
cases:14.47%
controls:12.20%
cases:15.13%
controls:6.11%
cases:4.61%
controls:0.69%
cases:0.82%
controls:0.00%
cases:6.88%
controls:0.66%
cases:13.76%
controls:6.04%
cases:24.21%
controls:20.15%
88
743
520
5347
92
372
516
5718
28
42
580
6048
5
0
603
6090
41
40
555
6025
71
352
445
5473
92
923
288
3657
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
5.8e-01
1.6e+00
—
—
3.1e+00
1.6e+00
3.7e-01
cases:4.61%
controls:2.64%
cases:5.10%
controls:1.10%
—
—
—
—
cases:2.52%
controls:0.12%
cases:5.04%
controls:1.08%
cases:6.58%
controls:4.63%
28
161
580
5929
31
67
577
6023
—
—
15
7
581
6058
26
63
490
5762
25
212
355
4368
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
7.7e-01
1.2e+00
2.0e+00
—
—
1.4e+00
8.5e-01
cases:5.43%
controls:2.58%
cases:2.63%
controls:0.79%
cases:0.99%
controls:0.13%
—
—
—
—
cases:2.71%
controls:0.70%
cases:6.05%
controls:2.69%
33
157
575
5933
16
48
592
6042
6
8
602
6082
—
—
14
41
502
5784
23
123
357
4457
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
8.3e-01
1.6e+00
2.3e+00
—
1.3e+00
1.5e+00
2.1e-01
cases:8.06%
controls:3.68%
cases:8.06%
controls:1.66%
cases:2.47%
controls:0.26%
—
—
cases:1.17%
controls:0.31%
cases:6.78%
controls:1.61%
cases:5.00%
controls:4.10%
49
224
559
5866
49
101
559
5989
15
16
593
6074
—
7
19
589
6046
35
94
481
5731
19
188
361
4392
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
6.4e-01
1.7e+00
—
1.0e+50
2.7e+00
1.1e+00
4.9e-01
cases:8.39%
controls:4.60%
cases:5.26%
controls:0.99%
—
—
cases:1.48%
controls:0.00%
cases:1.68%
controls:0.12%
cases:2.91%
controls:0.94%
cases:5.79%
controls:3.62%
51
280
557
5810
32
60
576
6030
—
9
0
599
6090
10
7
586
6058
15
55
501
5770
22
166
358
4414
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
8.1e-01
3.1e+00
—
1.0e+50
—
1.9e+00
1.2e+00
cases:1.32%
controls:0.59%
cases:4.44%
controls:0.21%
—
—
cases:2.14%
controls:0.00%
—
—
cases:3.10%
controls:0.46%
cases:4.47%
controls:1.42%
8
36
600
6054
27
13
581
6077
—
13
0
595
6090
—
16
27
500
5798
17
65
363
4515
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
7.8e-01
2.3e+00
—
—
—
2.4e+00
1.5e+00
cases:1.32%
controls:0.61%
cases:1.81%
controls:0.18%
—
—
—
—
—
—
cases:2.71%
controls:0.26%
cases:2.89%
controls:0.68%
8
37
600
6053
11
11
597
6079
—
—
—
14
15
502
5810
11
31
369
4549
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
7.4e-01
1.6e+00
2.7e+00
—
—
1.9e+00
6.7e-01
cases:1.81%
controls:0.87%
cases:3.13%
controls:0.67%
cases:1.97%
controls:0.13%
—
—
—
—
cases:3.68%
controls:0.58%
cases:4.21%
controls:2.21%
11
53
597
6037
19
41
589
6049
12
8
596
6082
—
—
19
34
497
5791
16
101
364
4479
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5810-7 [3019150]
2.2e-01
6.9e-01
2.4e+00
—
2.3e+00
8.0e-01
1.7e-02
cases:7.89%
controls:6.45%
cases:7.24%
controls:3.78%
cases:4.28%
controls:0.41%
—
—
cases:4.03%
controls:0.43%
cases:7.75%
controls:3.64%
cases:10.26%
controls:10.11%
48
393
560
5697
44
230
564
5860
26
25
582
6065
—
24
26
572
6039
40
212
476
5613
39
463
341
4117
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
7.5e-01
2.3e+00
—
—
—
2.4e+00
1.4e+00
cases:1.32%
controls:0.62%
cases:1.81%
controls:0.18%
—
—
—
—
—
—
cases:2.71%
controls:0.26%
cases:2.89%
controls:0.70%
8
38
600
6052
11
11
597
6079
—
—
—
14
15
502
5810
11
32
369
4548
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
5.5e-01
1.3e+00
2.3e+00
1.0e+50
—
1.3e+00
7.2e-01
cases:7.89%
controls:4.71%
cases:5.26%
controls:1.54%
cases:1.48%
controls:0.15%
cases:0.99%
controls:0.00%
—
—
cases:5.62%
controls:1.65%
cases:10.79%
controls:5.57%
48
287
560
5803
32
94
576
5996
9
9
599
6081
6
0
602
6090
—
29
96
487
5729
41
255
339
4325
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
8.7e-01
2.4e+00
—
—
—
2.4e+00
1.2e+00
cases:1.48%
controls:0.62%
cases:3.95%
controls:0.36%
—
—
—
—
—
—
cases:2.13%
controls:0.19%
cases:3.16%
controls:0.94%
9
38
599
6052
24
22
584
6068
—
—
—
11
11
505
5814
12
43
368
4537
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
94759-8 [586526]
9.7e-01
1.9e+00
2.6e+00
—
—
1.5e+00
5.7e-01
cases:1.97%
controls:0.76%
cases:2.47%
controls:0.36%
cases:1.32%
controls:0.10%
—
—
—
—
cases:2.52%
controls:0.55%
cases:3.16%
controls:1.81%
12
46
596
6044
15
22
593
6068
8
6
600
6084
—
—
13
32
503
5793
12
83
368
4497
calcium carbonate
A02AC01 [21600065]
A02AC01 [21600065]
1.5e+00
2.2e+00
—
—
—
2.2e+00
1.7e+00
cases:1.32%
controls:0.30%
cases:1.48%
controls:0.16%
—
—
—
—
—
—
cases:1.74%
controls:0.21%
cases:2.11%
controls:0.39%
8
18
600
6072
9
10
599
6080
—
—
—
9
12
507
5813
8
18
372
4562
calcium carbonate; oral
A12AA04 [21600863]
A12AA04 [21600863]
1.5e+00
2.2e+00
—
—
—
2.2e+00
1.7e+00
cases:1.32%
controls:0.30%
cases:1.48%
controls:0.16%
—
—
—
—
—
—
cases:1.74%
controls:0.21%
cases:2.11%
controls:0.39%
8
18
600
6072
9
10
599
6080
—
—
—
9
12
507
5813
8
18
372
4562
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
5.3e-01
1.0e+00
1.6e+00
1.0e+50
2.1e+00
7.2e-01
5.2e-01
cases:11.02%
controls:6.77%
cases:6.74%
controls:2.53%
cases:1.64%
controls:0.33%
cases:2.63%
controls:0.00%
cases:2.18%
controls:0.26%
cases:5.81%
controls:2.92%
cases:11.05%
controls:6.88%
67
412
541
5678
41
154
567
5936
10
20
598
6070
16
0
592
6090
13
16
583
6049
30
170
486
5655
42
315
338
4265
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
1.6e+00
1.8e+00
—
—
—
2.6e+00
1.1e+00
cases:2.96%
controls:0.59%
cases:1.32%
controls:0.21%
—
—
—
—
—
—
cases:1.74%
controls:0.14%
cases:1.32%
controls:0.44%
18
36
590
6054
8
13
600
6077
—
—
—
9
8
507
5817
5
20
375
4560
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
77147-7 [46236952]
1.2e+00
4.5e-01
2.5e+00
—
2.3e+00
1.0e+00
6.5e-01
cases:5.76%
controls:1.87%
cases:1.48%
controls:0.95%
cases:0.99%
controls:0.08%
—
—
cases:1.17%
controls:0.12%
cases:2.33%
controls:0.86%
cases:4.74%
controls:2.53%
35
114
573
5976
9
58
599
6032
6
5
602
6085
—
7
7
589
6058
12
50
504
5775
18
116
362
4464
Monoclonal gammopathy of undetermined significance (MGUS)
D47.2 [45566693]
D47.2 [45566693]
—
—
—
—
—
3.0e+00
3.0e+00
—
—
—
—
—
—
—
—
—
—
cases:2.71%
controls:0.14%
cases:4.47%
controls:0.24%
—
—
—
—
—
14
8
502
5817
17
11
363
4569
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
3.3e-01
6.4e-01
1.8e+00
—
2.0e+00
6.8e-01
5.6e-01
cases:36.68%
controls:29.44%
cases:15.30%
controls:8.67%
cases:5.76%
controls:1.02%
—
—
cases:6.88%
controls:1.02%
cases:15.89%
controls:8.72%
cases:37.11%
controls:25.28%
223
1793
385
4297
93
528
515
5562
35
62
573
6028
—
41
62
555
6003
82
508
434
5317
141
1158
239
3422
Localized oedema
R60.0 [45597193]
R60.0 [45597193]
1.0e+00
1.3e+00
2.3e+00
1.0e+50
—
1.3e+00
-4.0e-03
cases:4.61%
controls:1.72%
cases:2.14%
controls:0.57%
cases:1.32%
controls:0.13%
cases:1.81%
controls:0.00%
—
—
cases:2.52%
controls:0.70%
cases:2.63%
controls:2.64%
28
105
580
5985
13
35
595
6055
8
8
600
6082
11
0
597
6090
—
13
41
503
5784
10
121
370
4459
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
1.7e-01
6.6e-01
2.1e+00
—
2.4e+00
8.0e-01
1.6e-01
cases:12.83%
controls:11.02%
cases:11.02%
controls:6.04%
cases:5.76%
controls:0.72%
—
—
cases:6.88%
controls:0.69%
cases:12.79%
controls:6.16%
cases:19.47%
controls:17.12%
78
671
530
5419
67
368
541
5722
35
44
573
6046
—
41
42
555
6023
66
359
450
5466
74
784
306
3796
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.5e-01
3.3e-01
9.9e-01
3.7e+00
8.9e-01
3.4e-01
1.9e-01
cases:78.13%
controls:75.50%
cases:75.33%
controls:68.72%
cases:53.29%
controls:29.74%
cases:39.80%
controls:1.64%
cases:50.00%
controls:29.15%
cases:77.13%
controls:70.66%
cases:88.42%
controls:86.31%
475
4598
133
1492
458
4185
150
1905
324
1811
284
4279
242
100
366
5990
298
1768
298
4297
398
4116
118
1709
336
3953
44
627
Ultrasound examination of lower leg veins
PH2AE [2001309451]
PH2AE [2001309451]
9.9e-01
1.7e+00
—
1.0e+50
—
2.0e+00
1.2e+00
cases:4.28%
controls:1.63%
cases:2.63%
controls:0.48%
—
—
cases:1.48%
controls:0.00%
—
—
cases:2.52%
controls:0.36%
cases:5.00%
controls:1.59%
26
99
582
5991
16
29
592
6061
—
9
0
599
6090
—
13
21
503
5804
19
73
361
4507
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
1.1e+00
2.4e+00
—
—
—
3.4e+00
1.4e+00
cases:1.32%
controls:0.43%
cases:1.97%
controls:0.18%
—
—
—
—
—
—
cases:3.10%
controls:0.10%
cases:2.11%
controls:0.55%
8
26
600
6064
12
11
596
6079
—
—
—
16
6
500
5819
8
25
372
4555
Cardiology
6 [38004451]
6 [38004451]
3.4e-01
7.5e-01
1.9e+00
—
1.5e+00
1.1e+00
5.0e-01
cases:19.90%
controls:15.09%
cases:14.14%
controls:7.19%
cases:5.59%
controls:0.85%
—
—
cases:4.70%
controls:1.07%
cases:16.67%
controls:6.27%
cases:24.47%
controls:16.38%
121
919
487
5171
86
438
522
5652
34
52
574
6038
—
28
65
568
6000
86
365
430
5460
93
750
287
3830
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
1.7e-01
2.2e+00
—
—
—
2.4e+00
1.2e+00
cases:0.99%
controls:0.84%
cases:2.30%
controls:0.26%
—
—
—
—
—
—
cases:2.71%
controls:0.26%
cases:3.95%
controls:1.27%
6
51
602
6039
14
16
594
6074
—
—
—
14
15
502
5810
15
58
365
4522
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
I26.9 [45552785]
6.8e-01
1.8e+00
—
—
2.5e+00
1.0e+00
1.4e+00
cases:1.48%
controls:0.76%
cases:1.97%
controls:0.33%
—
—
—
—
cases:1.34%
controls:0.12%
cases:1.16%
controls:0.43%
cases:3.16%
controls:0.76%
9
46
599
6044
12
20
596
6070
—
—
8
7
588
6058
6
25
510
5800
12
35
368
4545
Malaise and fatigue
R53 [45553741]
R53 [45553741]
7.7e-01
1.2e+00
1.7e+00
1.0e+50
2.0e+00
1.1e+00
6.3e-01
cases:6.58%
controls:3.15%
cases:4.77%
controls:1.51%
cases:1.15%
controls:0.21%
cases:2.14%
controls:0.00%
cases:1.51%
controls:0.20%
cases:5.04%
controls:1.80%
cases:10.26%
controls:5.76%
40
192
568
5898
29
92
579
5998
7
13
601
6077
13
0
595
6090
9
12
587
6053
26
105
490
5720
39
264
341
4316
Implantation of vascular injection port
TPX10 [2001309608]
TPX10 [2001309608]
1.8e+00
3.2e+00
—
—
—
2.4e+00
—
cases:0.82%
controls:0.13%
cases:2.47%
controls:0.10%
—
—
—
—
—
—
cases:1.16%
controls:0.10%
—
—
5
8
603
6082
15
6
593
6084
—
—
—
6
6
510
5819
—
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
3.8e-01
1.2e+00
1.6e+00
—
1.8e+00
1.1e+00
2.6e-01
cases:5.92%
controls:4.14%
cases:4.77%
controls:1.54%
cases:1.48%
controls:0.31%
—
—
cases:2.01%
controls:0.33%
cases:5.43%
controls:1.84%
cases:6.58%
controls:5.17%
36
252
572
5838
29
94
579
5996
9
19
599
6071
—
12
20
584
6045
28
107
488
5718
25
237
355
4343
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
3.2e-01
1.3e+00
—
—
2.3e+00
1.2e+00
8.7e-01
cases:6.41%
controls:4.75%
cases:4.28%
controls:1.25%
—
—
—
—
cases:0.84%
controls:0.08%
cases:2.33%
controls:0.70%
cases:5.53%
controls:2.40%
39
289
569
5801
26
76
582
6014
—
—
5
5
591
6060
12
41
504
5784
21
110
359
4470
Weakness/tiredness general
A04 [2002000145]
A04 [2002000145]
-1.7e-01
6.9e-01
2.0e+00
—
2.7e+00
1.0e+00
2.9e-01
cases:1.97%
controls:2.33%
cases:1.81%
controls:0.92%
cases:1.15%
controls:0.16%
—
—
cases:1.85%
controls:0.13%
cases:3.29%
controls:1.20%
cases:5.00%
controls:3.78%
12
142
596
5948
11
56
597
6034
7
10
601
6080
—
11
8
585
6057
17
70
499
5755
19
173
361
4407
Other seropositive rheumatoid arthritis
M05.8 [45538634]
M05.8 [45538634]
8.2e-01
8.1e-01
1.8e+00
—
1.9e+00
1.1e+00
5.4e-01
cases:3.62%
controls:1.63%
cases:2.80%
controls:1.26%
cases:1.48%
controls:0.25%
—
—
cases:1.51%
controls:0.23%
cases:3.49%
controls:1.17%
cases:2.89%
controls:1.70%
22
99
586
5991
17
77
591
6013
9
15
599
6075
—
9
14
587
6051
18
68
498
5757
11
78
369
4502
Oxygen saturation in Capillary blood
2709-4 [3021901]
2709-4 [3021901]
1.7e+00
2.7e+00
—
—
—
1.5e+00
1.2e+00
cases:1.32%
controls:0.25%
cases:1.64%
controls:0.11%
—
—
—
—
—
—
cases:1.36%
controls:0.31%
cases:3.42%
controls:1.00%
8
15
600
6075
10
7
598
6083
—
—
—
7
18
509
5807
13
46
367
4534
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
6.4e-01
1.6e+00
2.8e+00
—
—
1.2e+00
4.4e-01
cases:3.45%
controls:1.86%
cases:3.45%
controls:0.74%
cases:1.32%
controls:0.08%
—
—
—
—
cases:2.71%
controls:0.84%
cases:5.53%
controls:3.62%
21
113
587
5977
21
45
587
6045
8
5
600
6085
—
—
14
49
502
5776
21
166
359
4414
Gastroenterology
10 [38004455]
10 [38004455]
5.6e-01
9.8e-01
1.1e+00
—
1.6e+00
1.5e+00
9.3e-01
cases:10.69%
controls:6.42%
cases:8.22%
controls:3.27%
cases:1.81%
controls:0.59%
—
—
cases:2.85%
controls:0.58%
cases:10.85%
controls:2.76%
cases:16.84%
controls:7.38%
65
391
543
5699
50
199
558
5891
11
36
597
6054
—
17
35
579
6030
56
161
460
5664
64
338
316
4242
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
1.4e+00
1.9e+00
—
—
—
2.3e+00
1.3e+00
cases:2.80%
controls:0.74%
cases:1.97%
controls:0.30%
—
—
—
—
—
—
cases:1.94%
controls:0.21%
cases:1.58%
controls:0.44%
17
45
591
6045
12
18
596
6072
—
—
—
10
12
506
5813
6
20
374
4560
Granulocytes [#/volume] in Blood
30394-1 [3035715]
30394-1 [3035715]
1.3e+00
1.7e+00
—
—
—
2.5e+00
1.5e+00
cases:2.47%
controls:0.69%
cases:1.48%
controls:0.28%
—
—
—
—
—
—
cases:1.94%
controls:0.15%
cases:1.32%
controls:0.28%
15
42
593
6048
9
17
599
6073
—
—
—
10
9
506
5816
5
13
375
4567
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
5.1e-01
9.0e-01
1.6e+00
—
1.7e+00
7.4e-01
2.6e-01
cases:12.99%
controls:8.26%
cases:10.86%
controls:4.70%
cases:4.44%
controls:0.89%
—
—
cases:5.03%
controls:0.96%
cases:8.72%
controls:4.34%
cases:12.63%
controls:10.00%
79
503
529
5587
66
286
542
5804
27
54
581
6036
—
30
58
566
6007
45
253
471
5572
48
458
332
4122
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
2.7e-01
1.0e+00
1.8e+00
—
2.0e+00
6.1e-01
6.7e-01
cases:10.53%
controls:8.26%
cases:6.25%
controls:2.38%
cases:1.64%
controls:0.26%
—
—
cases:2.52%
controls:0.36%
cases:4.65%
controls:2.58%
cases:14.74%
controls:8.12%
64
503
544
5587
38
145
570
5945
10
16
598
6074
—
15
22
581
6043
24
150
492
5675
56
372
324
4208
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
6.8e-01
2.2e+00
—
1.0e+50
—
3.3e+00
1.4e+00
cases:1.48%
controls:0.76%
cases:1.81%
controls:0.21%
—
—
cases:0.82%
controls:0.00%
—
—
cases:2.71%
controls:0.10%
cases:2.11%
controls:0.52%
9
46
599
6044
11
13
597
6077
—
5
0
603
6090
—
14
6
502
5819
8
24
372
4556
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
1.5e+00
2.2e+00
—
—
—
3.2e+00
1.4e+00
cases:1.32%
controls:0.30%
cases:1.64%
controls:0.18%
—
—
—
—
—
—
cases:2.52%
controls:0.10%
cases:1.84%
controls:0.46%
8
18
600
6072
10
11
598
6079
—
—
—
13
6
503
5819
7
21
373
4559
Palliative care
Z51.5 [45547323]
Z51.5 [45547323]
—
—
—
—
2.6e+00
1.7e+00
1.1e+00
—
—
—
—
—
—
—
—
cases:2.18%
controls:0.16%
cases:2.33%
controls:0.41%
cases:3.95%
controls:1.38%
—
—
—
—
13
10
583
6055
12
24
504
5801
15
63
365
4517
Neurology
13 [38004458]
13 [38004458]
3.0e-01
9.7e-01
1.2e+00
—
1.4e+00
1.1e+00
7.3e-01
cases:15.63%
controls:12.07%
cases:12.01%
controls:4.91%
cases:2.63%
controls:0.82%
—
—
cases:3.02%
controls:0.74%
cases:12.79%
controls:4.62%
cases:21.58%
controls:11.68%
95
735
513
5355
73
299
535
5791
16
50
592
6040
—
18
45
578
6020
66
269
450
5556
82
535
298
4045
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
6.2e-01
7.6e-01
1.1e+00
—
2.0e+00
1.1e+00
8.4e-01
cases:12.34%
controls:7.03%
cases:5.10%
controls:2.45%
cases:0.99%
controls:0.33%
—
—
cases:2.01%
controls:0.26%
cases:5.81%
controls:1.92%
cases:15.00%
controls:7.10%
75
428
533
5662
31
149
577
5941
6
20
602
6070
—
12
16
584
6049
30
112
486
5713
57
325
323
4255
Differential panel - Pleural fluid
29583-2 [3012441]
29583-2 [3012441]
2.3e+00
3.1e+00
1.0e+50
—
1.0e+50
—
1.8e+00
cases:0.99%
controls:0.10%
cases:2.14%
controls:0.10%
cases:0.82%
controls:0.00%
—
—
cases:2.01%
controls:0.00%
—
—
cases:1.58%
controls:0.26%
6
6
602
6084
13
6
595
6084
5
0
603
6090
—
12
0
584
6065
—
6
12
374
4568
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
4.0e-01
2.0e+00
—
—
—
1.8e+00
1.5e+00
cases:2.14%
controls:1.44%
cases:2.47%
controls:0.33%
—
—
—
—
—
—
cases:2.91%
controls:0.48%
cases:6.58%
controls:1.62%
13
88
595
6002
15
20
593
6070
—
—
—
15
28
501
5797
25
74
355
4506
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
203
486
5.76
84.53
4.4
2.9
63.02
66.26
g/l
4.26
193
436
181
405
5.93
80.90
4.6
2.5
10.52
10.72
g/l
0.15
171
370
285
944
4.79
79.50
4.1
2.6
11.92
12.80
umol/l
1.08
272
877
158
318
6.36
78.90
3.5
1.7
1.50
1.23
g/l
0.48
150
292
272
884
4.75
77.41
4.0
2.6
2.12
2.29
g/l
4.54
263
817
121
189
7.74
77.11
5.4
4.7
91.58
55.01
mg/l
0.44
92
163
121
190
7.70
76.72
5.4
4.6
47.70
52.50
mg/l
0.23
93
162
257
827
4.64
73.49
4.1
2.6
22.03
22.20
%
0.06
244
770
111
173
7.62
70.63
5.3
4.3
8.58
2.81
ratio
0.38
57
106
206
664
4.17
56.75
6.7
4.4
233.74
258.62
u/l
1.02
200
632
451
2503
4.08
53.90
11.2
4.9
31.38
35.34
g/l
24.83
433
2335
114
258
5.20
48.75
2.5
1.8
0.89
2.68
ug/l
0.88
109
225
171
551
3.92
46.10
2.9
2.2
0.19
0.21
g/l
2.78
157
517
206
768
3.54
44.41
12.2
5.5
1.06
1.03
mmol/l
0.67
199
709
476
2929
3.85
44.40
11.3
6.6
10.84
11.99
umol/l
1.62
466
2804
238
972
3.38
44.31
6.7
3.3
0.79
0.81
mmol/l
2.07
232
918
95
201
5.41
43.67
6.0
3.0
2.40
1.48
g/l
0.75
83
176
483
3041
3.83
42.52
18.2
9.7
4.73
4.21
e9/l
4.44
450
2654
303
1495
3.04
39.82
2.9
2.2
3.17
3.00
mg/l
0.60
268
1282
98
230
4.89
39.81
5.1
2.7
3.98
4.23
g/l
1.48
93
208
98
230
4.89
39.81
5.1
2.7
7.42
7.33
g/l
0.16
93
208
98
230
4.89
39.81
5.1
2.7
3.94
3.56
g/l
1.01
93
208
84
176
5.38
38.90
5.2
2.9
0.09
0.03
g/l
0.30
76
157
332
1767
2.93
37.26
3.4
2.5
55.34
106.81
u/l
0.59
316
1640
270
1287
2.97
37.19
4.1
2.6
4.55
5.17
e6/l
0.59
258
1173
80
167
5.36
37.15
2.5
1.6
—
—
—
0
0
91
214
4.82
36.77
5.4
2.8
3.08
3.02
g/l
0.20
86
192
154
545
3.44
35.15
2.7
2.6
69.13
67.85
e9/l
0.17
115
429
405
2446
2.95
35.04
5.1
3.1
241.99
133.00
ug/l
4.16
383
2257
230
1033
2.97
34.90
2.4
1.9
—
—
—
0
0
334
1845
2.79
33.93
5.2
3.4
39.29
91.84
e6/l
0.81
294
1422
227
1044
2.87
32.58
2.7
1.4
2.56
2.55
g/l
0.03
186
601
440
2851
2.95
32.03
15.9
7.2
1.21
1.21
mmol/l
0.10
379
2469
355
2064
2.72
31.94
6.3
4.0
104.85
129.22
e6/l
0.23
297
1483
427
2734
2.87
31.60
22.8
14.8
1.29
1.27
inr
0.32
373
2276
75
174
4.77
30.64
5.6
2.9
0.00
0.00
g/l
-0.00
66
148
406
2559
2.75
30.51
15.1
6.6
1.20
1.21
mmol/l
2.08
387
2346
547
4081
4.30
30.11
17.6
8.3
88.49
79.46
u/l
3.72
536
3841
291
1584
2.60
29.18
5.2
3.2
0.29
0.51
e6/l
1.78
247
1173
79
202
4.34
28.52
5.5
2.8
10.64
10.85
g/l
0.11
74
178
138
516
3.16
28.26
17.0
6.8
10.96
10.31
mmol/l
0.46
130
492
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
76
190
4.43
28.24
3.8
2.3
0.40
0.37
iu/ml
0.18
43
94
177
777
2.80
27.01
2.2
1.9
—
—
—
0
0
169
727
2.83
26.78
2.2
1.9
—
—
—
0
0
90
267
3.78
26.43
2.0
1.8
1.75
1.51
g/l
1.31
76
236
139
544
3.01
26.14
2.6
1.9
362.56
386.34
nmol/l
0.74
132
514
52
104
5.37
25.14
6.5
5.8
169.56
421.13
iu/ml
—
9
15
374
2415
2.42
24.31
3.3
2.4
76.48
77.63
nmol/l
0.29
354
2153
45
82
5.85
24.02
1.7
1.4
130.29
164.95
au/ml
0.73
12
21
369
2380
2.39
23.88
29.0
11.5
0.00
0.00
e9/l
1.06
327
1961
42
74
6.02
23.19
2.0
1.3
1658.16
1765.60
e6/l
0.07
31
50
316
1938
2.31
22.57
4.7
3.5
2.31
2.35
mmol/l
6.87
300
1750
185
901
2.51
22.33
4.4
2.0
30.82
29.54
s
1.69
179
873
42
77
5.78
22.26
2.1
1.7
—
—
—
0
0
309
1887
2.29
22.17
4.7
3.3
3128.67
1345.31
ng/l
3.39
287
1634
61
156
4.23
21.89
1.8
1.5
0.06
0.12
iu/ml
0.30
15
30
477
3543
2.59
21.19
6.9
4.9
247.29
2397.93
e6/l
—
7
60
284
1714
2.23
20.51
2.0
1.7
18.93
20.46
nmol/l
0.92
260
1424
452
3299
2.43
20.47
10.6
5.1
6.83
6.70
mmol/l
0.75
441
3143
72
218
3.61
20.37
2.5
2.7
—
—
—
0
0
247
1416
2.25
20.16
4.4
2.9
353.02
349.54
umol/l
0.18
227
1237
108
425
2.87
19.74
2.5
1.6
—
—
—
0
0
99
376
2.95
19.28
5.3
3.9
2.51
1.93
mmol/l
0.81
74
274
134
598
2.59
19.12
6.8
3.4
—
—
—
0
0
506
3940
2.67
19.04
8.3
4.3
20.43
12.46
mm/h
12.95
490
3650
30
46
6.81
18.91
2.4
1.7
—
—
—
0
0
71
226
3.42
18.57
2.0
2.3
40.74
38.89
u/l
0.27
63
201
140
648
2.51
18.45
3.8
2.5
7.79
8.27
umol/l
0.15
117
573
58
162
3.85
18.42
2.1
1.6
—
—
—
0
0
40
84
5.03
18.25
3.9
3.3
606.00
3410.88
u/ml
—
5
8
55
149
3.96
18.22
2.0
1.4
—
—
—
0
0
217
1227
2.19
17.89
3.4
1.7
1.61
1.26
mg/l
0.84
184
956
67
217
3.35
17.03
1.9
2.0
9.77
8.39
iu/ml
0.10
13
56
106
446
2.67
16.91
5.5
3.8
5.35
5.15
kpa
1.49
101
427
37
78
4.99
16.80
1.6
1.7
31.54
32.73
pg
0.78
37
78
184
995
2.22
16.78
2.0
1.7
1251.08
1174.45
nmol/l
0.46
152
752
83
308
2.96
16.77
1.8
1.4
—
—
—
0
0
277
1759
2.05
16.51
3.0
2.2
175.23
183.73
u/l
0.14
263
1666
44
110
4.23
16.22
2.2
1.9
—
—
—
0
0
131
624
2.40
16.03
9.0
3.3
5.84
5.76
kpa
0.36
131
604
56
168
3.57
16.00
2.1
1.7
—
—
—
0
0
53
155
3.65
15.73
1.9
1.6
—
—
—
0
0
275
1772
2.00
15.45
4.1
3.2
42.71
32.14
u/l
1.35
260
1677
38
88
4.54
15.43
1.7
1.3
215.21
251.37
u/ml
0.29
28
40
32
64
5.22
15.41
1.9
1.3
22005.14
48252.00
e6/l
0.56
22
34
358
2535
2.00
15.27
2.7
2.2
91.70
96.21
pmol/l
1.17
246
1323
46
125
3.90
15.16
2.2
2.5
30.86
33.03
umol/l
0.28
37
115
328
2258
1.98
15.13
6.4
4.1
120.42
78.99
ng/l
0.27
277
1720
104
457
2.54
15.10
9.7
4.1
1.21
1.22
mmol/l
1.85
96
390
125
602
2.35
14.83
9.3
3.4
2.09
1.96
mmol/l
0.15
115
516
442
3393
2.10
14.80
5.2
3.3
70.55
51.96
u/l
2.19
421
3168
26
23
11.75
14.40
2.8
3.0
1396.62
797.70
u/ml
1.07
26
23
97
431
2.49
13.69
6.3
4.0
133.03
89.57
ng/l
2.15
86
381
31
67
4.82
13.67
1.3
1.3
—
—
—
0
0
41
111
3.89
13.58
5.5
3.2
10.63
9.55
pmol/l
0.20
41
111
111
530
2.34
13.34
7.4
3.0
4.56
4.48
kpa
0.11
111
514
198
1191
1.98
13.08
1.8
1.8
83815458.70
21814918.92
pmol/l
0.33
173
981
42
119
3.72
13.04
2.0
1.5
—
—
—
0
0
124
628
2.22
12.94
4.1
4.5
259.29
32.30
ug/l
0.45
106
530
26
51
5.28
12.79
1.8
2.9
819.00
875.06
mg
0.07
26
51
380
2841
1.90
12.76
5.9
4.1
11.83
2.62
estimate
0.35
126
620
382
2864
1.89
12.68
5.9
4.2
0.00
0.52
estimate
0.51
116
580
45
137
3.47
12.57
1.3
1.2
—
—
—
0
0
25
28
9.26
12.34
2.3
1.9
—
—
—
0
0
374
2802
1.87
12.25
5.9
4.1
0.00
0.00
estimate
0.50
121
608
32
78
4.27
12.19
2.3
1.7
—
—
—
0
0
244
1620
1.84
11.65
6.1
4.1
0.00
0.01
estimate
1.15
112
557
44
139
3.33
11.60
2.0
1.5
—
—
—
0
0
48
162
3.13
11.37
1.4
1.5
246.63
267.90
ug/g
0.24
26
99
156
901
1.98
11.36
4.4
3.1
2.84
2.21
e6/l
0.53
91
468
54
197
2.91
11.18
1.3
1.3
—
—
—
0
0
91
444
2.23
10.28
4.8
2.8
54.33
63.26
ml/min/173m2
1.27
45
205
20
38
5.41
10.17
2.8
1.6
—
—
—
0
0
24
54
4.59
10.10
1.3
1.1
—
—
—
0
0
41
137
3.14
9.88
1.7
1.2
—
—
—
0
0
21
43
5.02
9.85
1.3
1.1
—
—
—
0
0
14
7
20.42
9.84
1.4
1.6
—
—
—
0
0
567
5066
2.69
9.51
47.4
17.1
33.03
25.40
mg/l
6.06
534
4213
185
1188
1.80
9.48
3.6
3.0
2.48
2.45
mmol/l
1.46
169
1063
21
45
4.80
9.36
1.3
1.1
—
—
—
0
0
21
45
4.80
9.36
1.3
1.1
—
—
—
0
0
21
45
4.80
9.36
1.3
1.1
—
—
—
0
0
271
1948
1.70
9.27
4.4
3.3
6.77
7.62
mmol/l
2.79
236
1618
22
50
4.53
9.15
1.3
1.1
—
—
—
0
0
122
694
1.95
9.11
10.0
7.6
1.55
0.95
mmol/l
0.76
106
574
99
523
2.07
9.09
3.5
2.2
35.80
33.79
u/l
0.14
83
441
333
2543
1.68
8.96
4.4
2.8
—
—
estimate
—
0
0
156
969
1.82
8.84
4.2
3.0
1.53
1.03
e6/l
0.91
91
538
36
120
3.13
8.72
2.3
1.6
—
—
—
0
0
22
52
4.35
8.72
1.3
1.4
—
—
—
0
0
21
33
6.55
8.55
2.8
1.7
—
—
—
0
0
288
2141
1.65
8.42
5.8
4.1
0.00
0.03
estimate
1.87
97
506
31
97
3.31
8.32
2.4
1.6
—
—
—
0
0
41
152
2.82
8.26
5.1
3.3
1.00
2.24
index
1.39
29
86
20
31
6.63
8.24
2.9
1.7
—
—
—
0
0
464
3933
1.75
7.92
5.2
4.2
14.88
14.89
pmol/l
0.02
436
3569
37
133
2.90
7.89
1.6
1.5
—
—
—
0
0
150
954
1.76
7.74
1.4
1.3
47.60
33.94
iu/ml
0.43
58
286
42
164
2.68
7.68
5.2
2.1
91.71
92.25
%
0.04
42
158
365
2922
1.62
7.62
3.0
2.9
—
—
—
0
0
19
45
4.33
7.52
2.1
1.2
—
—
—
0
0
86
462
2.00
7.50
4.7
3.3
251.73
224.93
ng/l
0.23
79
425
32
109
3.04
7.50
1.4
1.3
—
—
—
0
0
32
109
3.04
7.50
1.4
1.3
—
—
—
0
0
109
637
1.87
7.41
2.7
2.3
285.57
113.91
ug/g
1.60
97
509
66
323
2.17
7.36
4.0
4.0
44.87
46.88
%
0.26
66
316
21
55
3.92
7.31
1.1
1.2
—
79.00
—
0
6
528
4692
1.93
7.20
6.2
5.3
2.05
1.95
mu/l
1.12
502
4292
10
5
20.30
7.15
1.1
1.0
—
—
—
0
0
75
390
2.05
7.15
2.1
1.7
—
—
—
0
0
257
1920
1.59
6.97
5.6
4.1
22.21
8.76
mg/mmol
2.21
183
1192
172
1167
1.66
6.91
1.4
1.3
0.97
1.36
u/ml
0.64
41
307
195
1374
1.62
6.71
4.0
2.5
—
—
—
0
0
13
15
8.83
6.58
1.4
1.7
14866.86
3996.11
e6/l
—
7
9
15
22
6.96
6.55
1.5
1.5
1.85
1.79
umol/l
0.08
15
16
21
60
3.59
6.49
1.3
1.1
—
—
—
0
0
14
19
7.51
6.44
1.4
1.5
711.11
1269.43
e6/l
—
9
14
87
494
1.89
6.44
2.5
2.5
6.28
7.50
ug/l
0.28
75
437
72
387
1.98
6.26
14.2
9.4
1.37
1.32
%
0.16
72
382
21
62
3.47
6.19
1.5
1.6
—
—
—
0
0
36
146
2.56
6.14
3.4
2.3
123.97
129.02
g/l
0.50
31
116
161
1109
1.61
5.98
5.3
4.1
144.08
258.44
ng/l
1.10
137
910
9
6
15.19
5.92
1.2
1.0
70.56
92.33
%
—
9
6
566
5228
2.15
5.79
48.0
20.6
138.94
139.64
mmol/l
7.14
561
5128
95
575
1.77
5.71
1.7
1.7
1.77
1.52
%
1.16
81
497
133
884
1.65
5.67
1.4
1.3
18.53
9.89
u/ml
0.48
52
328
566
5235
2.13
5.65
49.1
20.8
4.00
3.99
mmol/l
0.21
561
5125
207
1529
1.54
5.63
5.6
3.6
0.00
0.06
estimate
0.66
99
479
11
13
8.59
5.58
1.2
1.0
—
—
—
0
0
11
14
7.98
5.36
1.1
1.0
—
—
—
0
0
28
110
2.62
5.12
1.4
1.2
11.87
16.75
e6/l
0.15
23
85
12
19
6.42
5.10
1.5
1.6
2.53
4.04
mmol/l
0.98
12
14
8
6
13.49
5.09
1.5
1.5
—
—
—
0
0
14
28
5.09
4.97
1.5
1.5
—
—
—
0
0
14
28
5.09
4.97
1.5
1.5
—
—
—
0
0
29
119
2.51
4.87
1.3
1.3
—
—
—
0
0
570
5327
2.07
4.86
24.5
12.4
25.19
25.29
u/l
0.06
563
5171
30
128
2.41
4.65
3.5
3.3
0.85
0.83
nmol/l
0.12
24
103
36
168
2.21
4.56
1.7
1.3
—
—
—
0
0
22
83
2.71
4.37
1.2
1.1
—
—
—
0
0
44
230
1.98
4.18
2.3
1.8
—
—
—
0
0
9
13
7.01
4.17
1.3
1.0
—
—
—
0
0
41
209
2.03
4.17
2.0
1.7
—
—
—
0
0
13
30
4.40
4.15
1.2
1.0
—
—
—
0
0
12
26
4.69
4.07
5.5
4.9
—
—
—
0
0
19
69
2.81
4.05
1.6
1.2
1.75
6.78
u/ml
—
8
23
11
23
4.85
3.88
1.5
1.3
3.38
52.65
ug/l
—
6
8
29
133
2.24
3.86
1.4
1.2
624.72
486.03
mg/l
0.36
29
124
32
153
2.15
3.85
1.8
1.3
—
—
—
0
0
12
28
4.35
3.83
1.2
1.1
0.64
0.50
ratio
—
6
15
527
4877
1.59
3.80
39.7
16.8
75.53
78.16
ml/min/173m2
1.64
506
4547
33
161
2.11
3.78
1.6
1.7
—
—
—
0
0
49
279
1.82
3.63
4.6
3.4
24.85
25.33
mmol/l
0.52
49
268
9
17
5.36
3.52
3.2
1.7
0.58
0.63
mmol/l
—
9
17
19
75
2.58
3.49
1.7
1.2
3.13
4.78
u/ml
—
8
32
575
5468
1.90
3.44
61.0
26.0
258.73
244.16
e9/l
4.40
568
5371
10
22
4.60
3.44
1.7
4.1
73.90
154.50
nmol/l
—
10
22
575
5470
1.89
3.41
60.9
26.0
4.19
4.45
e12/l
23.00
568
5352
52
312
1.73
3.25
1.3
1.2
38.57
126.76
u/ml
3.98
17
126
13
39
3.38
3.24
1.2
1.2
—
—
—
0
0
13
39
3.38
3.24
1.2
1.0
—
—
—
0
0
7
11
6.42
3.19
1.0
1.1
—
—
—
0
0
14
50
2.84
3.10
1.3
1.1
92.29
98.56
%
0.30
14
45
13
45
2.93
3.04
1.7
3.0
8.09
8.06
mmol/l
0.01
13
45
10
26
3.89
2.99
1.4
1.7
—
—
—
0
0
9
22
4.14
2.89
5.1
1.8
39.24
41.07
g/l
—
9
22
11
33
3.38
2.82
1.4
1.6
—
—
—
0
0
11
33
3.38
2.82
1.4
1.6
—
—
—
0
0
11
33
3.38
2.82
1.4
1.6
—
—
—
0
0
11
33
3.38
2.82
1.4
1.6
—
—
—
0
0
525
4926
1.47
2.79
5.8
5.3
6.07
6.01
mmol/l
0.40
483
4484
28
147
1.95
2.70
2.5
2.5
40.45
133.22
ug/min
1.65
17
90
9
24
3.79
2.68
1.3
1.1
—
—
—
0
0
16
67
2.43
2.65
1.3
1.1
—
—
—
0
0
14
55
2.58
2.63
1.4
1.4
—
—
—
0
0
5
7
7.19
2.55
7.4
15.9
4.42
5.29
mmol/l
—
5
7
9
26
3.50
2.49
1.4
1.7
—
—
—
0
0
9
26
3.50
2.49
1.4
1.7
—
—
—
0
0
21
104
2.06
2.39
1.0
1.2
48.44
48.75
u/l
0.00
21
90
15
68
2.24
2.12
7.0
3.9
—
—
—
0
0
500
4711
1.34
2.07
4.6
4.4
1.35
1.27
mmol/l
1.53
457
4291
154
1259
1.30
2.04
5.2
4.3
1.02
1.02
kg/l
0.53
115
845
8
27
2.99
1.94
1.0
1.2
—
—
—
0
0
11
45
2.47
1.94
1.1
1.1
—
—
—
0
0
9
33
2.75
1.93
1.0
1.0
—
—
—
0
0
35
221
1.62
1.89
1.5
1.5
0.22
0.41
mg/l
1.67
16
97
9
35
2.59
1.80
5.4
1.9
—
—
—
0
0
518
4930
1.34
1.80
5.4
5.2
1.40
1.45
mmol/l
1.71
475
4527
520
4955
1.34
1.77
5.4
5.3
4.35
4.53
mmol/l
3.35
480
4582
9
36
2.52
1.74
1.0
1.2
90.67
99.78
pmol/l
—
9
36
8
30
2.69
1.73
1.3
1.3
—
—
—
0
0
7
24
2.94
1.72
1.1
1.1
—
—
—
0
0
139
1147
1.27
1.70
3.8
3.2
0.80
0.72
ug/l
0.57
97
755
10
40
2.52
1.67
7.4
3.0
0.40
0.93
index
—
10
40
7
25
2.82
1.65
1.1
1.1
—
—
—
0
0
226
1983
1.22
1.59
6.8
5.2
3.45
2.33
ug/l
1.42
202
1761
25
152
1.67
1.59
1.4
1.2
—
—
—
0
0
7
26
2.71
1.58
3.7
3.5
0.79
1.15
%
—
7
26
12
57
2.13
1.56
1.3
1.6
—
—
—
0
0
12
57
2.13
1.56
1.3
1.6
—
—
—
0
0
12
57
2.13
1.56
1.3
1.6
—
—
—
0
0
25
153
1.66
1.55
1.4
1.2
—
—
—
0
0
527
5053
1.32
1.54
6.0
6.0
2.47
2.63
mmol/l
3.73
487
4645
7
27
2.61
1.52
1.0
1.1
—
—
—
0
0
7
27
2.61
1.52
1.0
1.0
2016.29
1618.11
miu/ml
—
7
27
11
51
2.18
1.51
1.7
1.3
7144.00
264416.69
e6/l
—
5
36
15
81
1.87
1.41
1.1
1.1
0.71
2.27
u/ml
—
9
41
24
152
1.60
1.33
1.5
1.3
—
—
—
0
0
13
69
1.90
1.29
1.6
1.8
—
—
—
0
0
26
170
1.55
1.28
3.8
3.3
1.45
1.54
mmol/l
0.30
26
165
11
55
2.02
1.28
1.0
1.1
—
—
—
0
0
19
115
1.67
1.26
2.1
2.3
1023.30
4237.73
u/l
—
9
38
8
36
2.24
1.24
1.1
1.1
—
—
—
0
0
21
132
1.61
1.22
1.4
1.4
223.51
239.99
miu/ml
—
8
67
8
37
2.18
1.21
1.1
1.1
—
—
—
0
0
11
57
1.95
1.17
1.1
1.1
—
—
—
0
0
12
65
1.86
1.14
1.7
1.8
—
—
—
0
0
12
66
1.83
1.09
1.9
1.4
—
—
—
0
0
13
74
1.77
1.07
5.5
5.1
329.92
360.37
umol/l
0.26
13
65
12
67
1.81
1.05
1.9
1.4
—
—
—
0
0
12
67
1.81
1.05
1.9
1.4
—
—
—
0
0
11
60
1.85
1.03
6.8
2.6
—
—
—
0
0
12
68
1.78
1.01
1.8
1.4
—
—
—
0
0
9
49
1.85
0.99
1.2
1.1
—
—
—
0
0
12
69
1.75
0.97
1.9
1.4
—
—
—
0
0
12
69
1.75
0.97
1.9
1.4
—
—
—
0
0
7
37
1.90
0.94
1.1
1.2
—
—
—
0
0
7
37
1.90
0.94
1.1
1.2
—
—
—
0
0
54
429
1.28
0.94
2.3
2.4
10.52
13.55
nmol/l
1.42
49
383
13
78
1.68
0.92
1.6
1.7
—
—
—
0
0
6
28
2.15
0.91
1.2
1.2
—
—
—
0
0
6
28
2.15
0.91
1.2
1.2
—
—
—
0
0
499
4823
1.19
0.91
8.1
6.7
40.27
39.66
mmol/mol
0.79
473
4489
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
31
232
1.35
0.83
1.4
1.3
—
—
—
0
0
175
1582
1.15
0.81
5.1
4.3
20.23
22.27
%
0.97
93
752
18
122
1.49
0.81
1.5
1.8
2.87
5.08
iu/l
—
9
49
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
53
638
0.81
0.71
1.5
1.5
—
—
—
0
0
20
143
1.41
0.71
3.0
1.5
244.89
291.97
mu/l
0.65
20
131
9
59
1.53
0.68
1.2
1.2
1.49
1.79
nmol/l
—
9
53
8
50
1.61
0.61
1.1
1.9
4.70
6.52
umol/l
—
8
33
6
37
1.63
0.55
1.2
1.2
—
—
—
0
0
90
800
1.15
0.55
1.5
1.6
—
—
—
0
0
9
60
1.51
0.54
1.3
1.3
—
—
—
0
0
21
168
1.26
0.40
1.4
1.8
—
—
—
0
0
227
2159
1.08
0.40
2.2
2.0
1.50
1.30
mmol/l
2.98
186
1782
5
34
1.47
0.40
2.6
2.4
—
—
—
0
0
10
136
0.73
0.38
1.1
1.1
1.54
1.54
g/l
—
10
136
11
143
0.76
0.32
1.7
1.1
0.86
0.91
g/l
0.22
11
143
28
240
1.17
0.30
1.1
1.0
—
—
—
0
0
10
130
0.77
0.29
1.8
2.0
152.40
220.12
pmol/l
—
10
120
8
107
0.74
0.29
8.0
4.3
26.14
22.43
mg/l
—
8
72
5
38
1.32
0.23
2.8
2.2
33.00
37.81
mg/l
—
5
32
24
209
1.15
0.23
1.5
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
1.03
—
0
6
0
12
0.00
0.21
0.0
1.8
—
8.70
—
0
7
0
12
0.00
0.21
0.0
1.1
—
1.16
—
0
12
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
40
374
1.07
0.13
2.0
1.8
—
—
—
0
0
46
434
1.06
0.12
1.5
1.5
—
—
—
0
0
5
60
0.83
0.08
1.4
1.2
8.76
7.85
mmol/l
—
5
48
17
156
1.09
0.08
1.8
2.0
56.71
40.64
nmol/l
0.81
17
147
71
695
1.02
0.04
4.5
5.1
31.43
32.01
%
0.17
44
448
62
633
0.98
0.03
9.2
7.5
—
—
—
0
0
42
409
1.03
0.03
2.1
1.9
—
—
—
0
0
13
134
0.97
0.00
1.5
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
8.20
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
6.47
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_OTHER_ABNORMALITI_PLASMA_PROTEINS – Other abnormalities of plasma proteins
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).